US20140030300A1 - Nanoparticle Compositions Providing Enhanced Color for Cosmetic Formulations - Google Patents
Nanoparticle Compositions Providing Enhanced Color for Cosmetic Formulations Download PDFInfo
- Publication number
- US20140030300A1 US20140030300A1 US14/040,800 US201314040800A US2014030300A1 US 20140030300 A1 US20140030300 A1 US 20140030300A1 US 201314040800 A US201314040800 A US 201314040800A US 2014030300 A1 US2014030300 A1 US 2014030300A1
- Authority
- US
- United States
- Prior art keywords
- composition
- nanoparticles
- compositions
- skin
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 223
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 123
- 239000002537 cosmetic Substances 0.000 title abstract description 38
- 238000009472 formulation Methods 0.000 title description 17
- 239000000049 pigment Substances 0.000 claims abstract description 83
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 74
- 239000006229 carbon black Substances 0.000 claims description 32
- 229910021485 fumed silica Inorganic materials 0.000 claims description 30
- 239000002245 particle Substances 0.000 claims description 26
- 239000000377 silicon dioxide Substances 0.000 claims description 22
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 12
- 229920001296 polysiloxane Polymers 0.000 claims description 11
- 230000002209 hydrophobic effect Effects 0.000 claims description 9
- 229920001577 copolymer Polymers 0.000 claims description 8
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920000178 Acrylic resin Polymers 0.000 claims description 2
- 239000004925 Acrylic resin Substances 0.000 claims description 2
- 239000001034 iron oxide pigment Substances 0.000 claims description 2
- 125000005375 organosiloxane group Chemical group 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 2
- 239000011118 polyvinyl acetate Substances 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims 1
- -1 dermatological Substances 0.000 abstract description 28
- 230000003287 optical effect Effects 0.000 abstract description 22
- 238000000034 method Methods 0.000 abstract description 14
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 4
- 235000019241 carbon black Nutrition 0.000 description 31
- 238000002835 absorbance Methods 0.000 description 22
- 239000001993 wax Substances 0.000 description 21
- 239000003921 oil Substances 0.000 description 19
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 18
- 239000000463 material Substances 0.000 description 18
- 230000001965 increasing effect Effects 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 17
- 206010040954 Skin wrinkling Diseases 0.000 description 16
- 230000000699 topical effect Effects 0.000 description 15
- 230000037303 wrinkles Effects 0.000 description 15
- 230000002708 enhancing effect Effects 0.000 description 13
- 230000032683 aging Effects 0.000 description 12
- 230000000475 sunscreen effect Effects 0.000 description 12
- 239000000516 sunscreening agent Substances 0.000 description 12
- 239000006071 cream Substances 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 11
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000003086 colorant Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 239000003981 vehicle Substances 0.000 description 9
- 241000872198 Serjania polyphylla Species 0.000 description 8
- 230000009102 absorption Effects 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 210000004209 hair Anatomy 0.000 description 8
- 229930195733 hydrocarbon Natural products 0.000 description 8
- 150000002430 hydrocarbons Chemical class 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000004408 titanium dioxide Substances 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 239000001023 inorganic pigment Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 210000000158 ommatidium Anatomy 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- 239000004215 Carbon black (E152) Substances 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000003974 emollient agent Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 238000004299 exfoliation Methods 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 5
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- 239000012860 organic pigment Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000002834 transmittance Methods 0.000 description 5
- 239000011787 zinc oxide Substances 0.000 description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000008406 cosmetic ingredient Substances 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 238000007665 sagging Methods 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- MNWFXJYAOYHMED-UHFFFAOYSA-N hexane carboxylic acid Natural products CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- CRTGSPPMTACQBL-UHFFFAOYSA-N 2,3-dihydroxycyclopent-2-en-1-one Chemical compound OC1=C(O)C(=O)CC1 CRTGSPPMTACQBL-UHFFFAOYSA-N 0.000 description 2
- XMVBHZBLHNOQON-UHFFFAOYSA-N 2-butyl-1-octanol Chemical compound CCCCCCC(CO)CCCC XMVBHZBLHNOQON-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N 2-methoxyethyl acetate Chemical compound COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- TYEYBOSBBBHJIV-UHFFFAOYSA-N 2-oxobutanoic acid Chemical compound CCC(=O)C(O)=O TYEYBOSBBBHJIV-UHFFFAOYSA-N 0.000 description 2
- KDVFRMMRZOCFLS-UHFFFAOYSA-N 2-oxopentanoic acid Chemical compound CCCC(=O)C(O)=O KDVFRMMRZOCFLS-UHFFFAOYSA-N 0.000 description 2
- WHSXTWFYRGOBGO-UHFFFAOYSA-N 3-methylsalicylic acid Chemical compound CC1=CC=CC(C(O)=O)=C1O WHSXTWFYRGOBGO-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229910052582 BN Inorganic materials 0.000 description 2
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010040799 Skin atrophy Diseases 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 230000003667 anti-reflective effect Effects 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 230000003810 hyperpigmentation Effects 0.000 description 2
- 208000000069 hyperpigmentation Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000282 nail Anatomy 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- LBTVHXHERHESKG-UHFFFAOYSA-N tetrahydrocurcumin Chemical compound C1=C(O)C(OC)=CC(CCC(=O)CC(=O)CCC=2C=C(OC)C(O)=CC=2)=C1 LBTVHXHERHESKG-UHFFFAOYSA-N 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- RWKSBJVOQGKDFZ-UHFFFAOYSA-N 16-methylheptadecyl 2-hydroxypropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)O RWKSBJVOQGKDFZ-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- FWIUBOWVXREPPL-UHFFFAOYSA-N 2-[2-(7-methyloctanoyloxy)ethoxy]ethyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OCCOCCOC(=O)CCCCCC(C)C FWIUBOWVXREPPL-UHFFFAOYSA-N 0.000 description 1
- HJZZQNLKBWJYPD-UHFFFAOYSA-N 2-[2-[2-(carboxymethoxy)ethoxy]ethoxy]acetic acid Chemical compound OC(=O)COCCOCCOCC(O)=O HJZZQNLKBWJYPD-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 1
- IKRKINIKITZMKG-UHFFFAOYSA-N 2-hydroxy-5-octylbenzoic acid Chemical compound CCCCCCCCC1=CC=C(O)C(C(O)=O)=C1 IKRKINIKITZMKG-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- HXVCOQUDJKMJQY-UHFFFAOYSA-N 2-octyldodecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC HXVCOQUDJKMJQY-UHFFFAOYSA-N 0.000 description 1
- CYSSSYKSBHKJQE-UHFFFAOYSA-N 2-undecylpentadecan-1-ol Chemical compound CCCCCCCCCCCCCC(CO)CCCCCCCCCCC CYSSSYKSBHKJQE-UHFFFAOYSA-N 0.000 description 1
- GFOUVESKDMJIJA-UHFFFAOYSA-N 4-heptoxy-2-hydroxybenzoic acid Chemical compound CCCCCCCOC1=CC=C(C(O)=O)C(O)=C1 GFOUVESKDMJIJA-UHFFFAOYSA-N 0.000 description 1
- VHDBCRXSHLVFGR-UHFFFAOYSA-N 5-decanoyl-2-hydroxybenzoic acid Chemical compound CCCCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 VHDBCRXSHLVFGR-UHFFFAOYSA-N 0.000 description 1
- NCYSBHWOHLGEQN-UHFFFAOYSA-N 5-dodecanoyl-2-hydroxybenzoic acid Chemical compound CCCCCCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 NCYSBHWOHLGEQN-UHFFFAOYSA-N 0.000 description 1
- DTRNDEHJGFRYBJ-UHFFFAOYSA-N 5-heptoxy-2-hydroxybenzoic acid Chemical compound CCCCCCCOC1=CC=C(O)C(C(O)=O)=C1 DTRNDEHJGFRYBJ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical group CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Natural products O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 206010040851 Skin fragility Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- SFRPDSKECHTFQA-ONOWFSFQSA-N [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] propanoate Chemical compound CCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SFRPDSKECHTFQA-ONOWFSFQSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- YACLQRRMGMJLJV-UHFFFAOYSA-N chloroprene Chemical compound ClC(=C)C=C YACLQRRMGMJLJV-UHFFFAOYSA-N 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000005534 decanoate group Chemical class 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- ATJVZXXHKSYELS-FNORWQNLSA-N ethyl (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(O)C(OC)=C1 ATJVZXXHKSYELS-FNORWQNLSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 229940027504 ethyl ferulate Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical class COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- ATJVZXXHKSYELS-UHFFFAOYSA-N ferulic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=C(O)C(OC)=C1 ATJVZXXHKSYELS-UHFFFAOYSA-N 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical class OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- LTYSCLBTUYRCBF-UHFFFAOYSA-N icosan-9-yl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OC(CCCCCCCC)CCCCCCCCCCC LTYSCLBTUYRCBF-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052809 inorganic oxide Inorganic materials 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 239000000236 nitric oxide synthase inhibitor Substances 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 125000005474 octanoate group Chemical class 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 229940093441 palmitoyl oligopeptide Drugs 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- DQAKJEWZWDQURW-UHFFFAOYSA-N pyrrolidonecarboxylic acid Chemical class OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000003370 receptor cell Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- CSYSULGPHGCBQD-UHFFFAOYSA-N s-ethylisothiouronium diethylphosphate Chemical compound CCSC(N)=N.CCOP(O)(=O)OCC CSYSULGPHGCBQD-UHFFFAOYSA-N 0.000 description 1
- 150000003870 salicylic acids Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037370 skin discoloration Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8117—Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8123—Compositions of homopolymers or copolymers of compounds having one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers, e.g. PVC, PTFE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention generally relates to cosmetic, dermatological, and pharmaceutical compositions and their use. More particularly the present invention relates to cosmetic compositions and their use in improving the appearance of biological surfaces.
- Modern skin care formulations must meet high standards of efficacy, skin compatibility and aesthetic appeal. Consumers are interested in mitigating or delaying the dermatological signs of chronologically-aged, hormonally-aged or photo-aged skin, such as fine lines, wrinkles, drying, and sagging skin, and other conditions due to a progressive degradation of the skin matrix. Consumers are interested in improving the appearance of, for example, skin, lips, nails, and hair by imparting to these biological surfaces a certain color, which would ideally produce an appearance of a uniform, lively, smooth and even surface, with no apparent imperfections. Therefore, there is a need for cosmetics that assist in creating a flawless, long lasting, lively coloring to improve the appearance of the biological surfaces.
- make-up compositions that are applied to biological surfaces to impart a certain color such as foundations, face powders, eyeshadows, lipsticks, concealers, blushers, mascaras, eyeliners, lip pencils, eye pencils, or nail varnishes have difficulty achieving a perfect, flawless lively color because cosmetic ingredients such as coloring agents, which provide the desired color and coverage, generally have many limitations.
- the coloring agents employed in such make-up compositions can be lakes, inorganic or organic pigments and/or pearlescent pigments, and alternatively dyes.
- Inorganic pigments, and in particular inorganic oxides have the advantage of being relatively stable, but have the drawback of imparting rather dull, pale colors to the material being colored.
- Organic lakes have the advantage of imparting lively colors to the compositions, but are relatively unstable with respect to light, temperature or pH. Some of these coloring agents also have the drawback of leaving unsightly marks on the skin or the nails after application. Pearlescent pigments allow varied, but not intense, colors to be obtained with iridescent effects.
- coloring agents have the drawback of generating free radicals in make-up formulations, which modify the color of the applied make-up and the stability of the compositions.
- Free radicals when present on the skin promote ageing of the skin such as the appearance of wrinkles, fine lines and yellowing of the skin.
- the compound eyes of insects are composed of ommatidia.
- the ommatidia have smooth surfaces, but some, such as those of moths and butterflies, are covered with tiny, slightly tapered protuberances.
- These structures are approximately 200 nanometers in both height and diameter at their base, and are arrayed across the surface of the ommatidia in a regular hexagonal pattern.
- These structures were first observed in nocturnal moths by W. H. Miller and colleagues in 1962 (Bernhard C. G. and Miller W. H. “A corneal nipple pattern in insect compound eyes,” Acta Physiol. Scand. 1962; 56:385-386).
- Such structures are shown and described in Vukusic, et al., Nature 2003, 424:852-856, for example, FIG. 7 .
- each ommatidium is made of chitin, which has a refractive index (1.55) higher than that of air (1.00).
- the protuberances work by providing a gradual transition in refractive index from air to ommatidium. Each individual photon that is incident on the ommatidia first encounters the thinner tops of the protuberances, making the effective refractive index only slightly higher than the refractive index of air. As the protuberance widens closer to the bottom, the refractive index of the surface approaches that of pure chitin. Because the size and periodicity of the protuberances are smaller than those of the optical wavelengths absorbed ( ⁇ ⁇ 500 nm), each individual photon encounters this gradual transition, and reflection from the surface is minimized. This is known as the “moth-eye principle” or the “moth-eye effect”.
- the moth-eye structure is well suited for many antireflective tasks.
- the inventive cosmetic formulations permit increased light absorption and provide increased color chroma while being relatively stable.
- a further object of the invention is to provide a composition comprising an effective amount of nanoparticles to produce the optical effects observed in the moth eye along with one or more pigments in a carrier which further produce unique optical effects on skin.
- a method of improving the aesthetic or natural appearance of a biological surface by applying to the biological surface a composition comprising an effective amount of nanoparticles to produce optical effects observed in the moth eye and one or more pigments in a carrier in an amount effective to improve the aesthetic or natural appearance of the biological surface.
- the composition is applied such that the appearance of dermatological signs of damaged or chronologically-aged, hormonally-aged, or photo-aged skin, such as fine lines, wrinkles, and sagging skin, surface imperfections, and discoloration is diminished.
- the composition is applied to a biological surface to add color, hide surface flaws, act as a photoprotectant, and make the surface appear smoother.
- compositions having an effective amount of nanoparticles along with pigments and combinations thereof, and methods of using such compositions for topical application in order to improve the aesthetic appearance of a biological surface.
- FIG. 1 shows a schematic representation of the anti-reflective “moth-eye” surface with the size of the moth-eye structure between 180 nm and 240 nm.
- This sub-visible light wavelength surface relief profile is a low reflectance interface for light.
- the moth's eye appears black and may absorb light from any direction.
- FIG. 2 shows the reflectance (total reflection (SCI) and scattering reflection (SCE)) of four systems: (1) 6.94% carbon black plus 2.78% hydrophobic silica; (2) 6.94% carbon black plus 2.78% hydrophobic fumed silica; (3) 6.94% carbon black plus 2.78% fumed silica and (4) 7.14% carbon black.
- SCI total reflection
- SCE scattering reflection
- FIG. 3 shows absorbance of the four (4) systems used in FIG. 2 .
- the figure shows that the addition of silica of any kind increases absorption.
- the reflection and absorption values for each system disclosed in Table 2 are shown in Table 3.
- FIG. 4 shows the reflectance (total reflection (SCI) and scattering reflection (SCE)) of five systems: (5) 6.94% carbon black plus 5.00% fumed silica; (6) 6.94% carbon black plus 7.00% fumed silica; (9) 9.00% carbon black plus 2.78% fumed silica; (11) 9.00% carbon black plus 5.00% fumed silica; and (4) 7.14% carbon black.
- SCI total reflection
- SCE scattering reflection
- FIG. 5 shows absorbance of the five systems used in FIG. 4 .
- the figure shows that the addition of fumed silica to carbon black increases absorption.
- FIG. 6 a shows the absorbance and FIG. 6 b shows the luminescence (L*) data for three (3) systems: 4.00% carbon black control with no nanoparticles, 4.00% carbon black with 4% silica shell nanoparticles, and 4.00% carbon black with 4.00% fumed silica nanoparticles.
- the figures shows that the addition of either 4.00% fumed silica nanoparticles or 4.00% silica shell nanoparticles results in increased absorbance and reduced luminescence resulting in enhanced contrast (darker) in comparison to the carbon black control (no nanoparticles).
- the full composition of each system is disclosed in Table 5.
- FIG. 7 a shows the total transmission
- FIG. 7 b shows the total reflectance and scattered reflectance data for three (3) systems: 4.00% carbon black control with no nanoparticles, 4.00% carbon black with 4.00% silica shell nanoparticles, and 4.00% carbon black with 4.00% fumed silica nanoparticles.
- the figures show that addition of 4.00% fumed silica nanoparticles results in increased transmission, reduced total reflectance and reduced scattered reflectance.
- Table 5 The reflection and absorption values for each system disclosed in Table 5 are shown in Table 6.
- the invention provides compositions comprising an effective amount of nanoparticles in combination with a pigment in an acceptable vehicle having a film former and/or wax to create optical effects observed in the moth eye which improve the aesthetic appearance of biological surfaces.
- the compositions for example, improve the appearance of biological surfaces damaged by the chronological aging process, the environment, or natural imperfections.
- the compositions also serve to beautify and decorate the biological surfaces.
- the compositions When applied to a surface, for example, a biological surface, the compositions enhance the appearance of the surface by enhancing absorbance, enhancing transmittance and reducing reflective properties.
- Enhancing the aesthetic appearance of the biological surfaces may be achieved by topical application of the inventive compositions to the biological surfaces on a daily basis or when a natural appearance or added color is desired.
- Biological surfaces include, but are not limited to, keratinous tissues, skin, hair, lips, eyelashes, eyebrows and nails.
- compositions of the invention alter the manner in which light reaches a biological surface so as to provide hiding, opacity, and coverage.
- inventive compositions comprise transparent or translucent nanoparticles along with a cosmetic pigment.
- the nanoparticles in combination with pigment present in a cosmetic composition are suitable for application to biological surfaces.
- nanoparticle refers to a nanometer-sized particle, having a diameter of between about 1 nanometer and about 999 nanometers; the term “nanoparticles” as used herein refers to nanometer-sized particles, nanoclusters, clusters, particles, small particles, and nanostructured materials.
- An effective amount of nanoparticle material in an acceptable carrier depends on factors including the weight ratio of nanoparticles plus pigment to film former and/or wax in the carrier, the surface area of each nanoparticle, the physical properties of the nanoparticles and the weight ratio of nanoparticles to the pigment.
- the pigment, carrier and nanoparticle material may each have a different refractive index so as to control light diffusion properties.
- the refractive index of the pigment is greater than the nanoparticle material to obtain optimal lateral light diffusion.
- the size of each nanoparticle is preferably less than the wavelength of visible light to enhance light absorption and reduce reflectance.
- Pigments suitable in this invention range in particle size from about 100 nanometers to about 10 microns. More preferably, pigment particle sizes range from about 100 nanometers to about 2 microns.
- Preferred inorganic pigments for use in this invention are those typically used in the personal care or cosmetic industry to provide hiding, coverage and/or color.
- the pigment material is about 0.5 microns; in another embodiment of the invention, pigment material is about 1.0 microns.
- Reference to the size of a pigment or nanoparticle means the length of the largest straight dimension of the pigment or nanoparticle.
- the size of a spherical pigment is its diameter
- the size of a spherical nanoparticle is its diameter.
- the refractive index of the pigments can be from about 1.38 to about 3.52; more preferably about 1.40 to about 3.50; more preferably about 1.42 to about 3.40; more preferably about 1.60 to about 3.40.
- Pigments having refractive indices of about 1.38 to about 3.52 include, but are not limited to, titanium dioxide (rutile or anatase), zinc oxide and iron oxide.
- the refractive indices of various materials may be evaluated using a refractometer. Details with respect to the principles of refraction can be found in Optics by Eugene Hecht (Fourth Edition), 2002. Details with respect to refractive indices of materials can be found in the CRC Handbook of Chemistry and Physics, 86th Edition, 2005-2006, which is herein incorporated by reference in its entirety.
- the composition is comprised of a combination of pigments of different refractive indices. In another embodiment of the invention, the composition is comprised of a single pigment.
- Suitable inorganic pigments include, but are not limited to, titanium dioxide, zirconium oxide and cerium oxide, as well as zinc oxide, iron oxide, chromium oxide and ferric blue.
- Suitable organic pigments include, but are not limited to, barium, strontium, calcium, and aluminum lakes and carbon black. Any pigment material of the inventive composition producing the desired effects may be used, non-limiting examples of which include a metal oxide, for example, titanium dioxide, iron oxide, and aluminum oxide.
- CTFA Cosmetic, Toiletry, and Fragrance Association
- the composition comprises titanium dioxide. In another embodiment, the composition comprises iron oxide. In another embodiment, the composition comprises carbon black.
- Organic and inorganic pigments suitable for use in this invention may be substantially solid or porous.
- the outer surface of the pigment is substantially solid and of uniform contour.
- Nanoparticles suitable to create the desired optical effects observed in the moth eye of this invention range in size from about 1 nm to about 900 nm; more preferably from about 7 nm to about 700 nm; more preferably from about 10 nm to about 500 nm.
- Mean particle sizes of nanoparticles of this invention range in size from about 10 nm to about 700 nm; more preferably from about 20 nm to about 500 nm; more preferably from about 30 nm to about 500 nm.
- the mean particle size of the nanoparticles may be about 10 nm, about 20 nm, about 50 nm, about 75 nm, about 100 nm, about 125 nm, about 150 nm, about 175 nm, about 200 nm, about 225 nm, about 250 nm, about 275 nm, about 300 nm, about 325 nm, about 350 nm, about 375 nm, about 400 nm, about 425 nm, about 450 nm, about 475 nm, or about 500 nm.
- the nanoparticles have a diameter below the wavelength of light they are interacting with, thereby producing the desired effects.
- the nanoparticles are smaller than the size of the pigment. In another embodiment of the invention, the nanoparticles are about the same size as the pigment. In yet another embodiment of the invention, the nanoparticles are larger than the size of the pigment.
- Nanoparticles suitable for this invention include, but are not limited to, nanoparticles made of fumed silica, metal oxides such as aluminum oxide, fumed alumina, zinc oxide, titanium dioxide or zirconium oxide, or polymeric nanoparticles such as poly(methyl methacrylate) (PMMA), nylon, polyethylene (PE), polystyrene (PS), polytetrafluoroethylene, or cellulosics.
- the refractive index of the nanoparticles can be from about 1.30 to about 3.50.
- the nanoparticle is fumed silica having a refractive index of about 1.46.
- the composition is comprised of a combination of nanoparticles of different refractive indices.
- the nanoparticles in the composition are capable of enhancing the absorption and/or altering the scattering behavior of visible light.
- the difference between the refractive indices of the cosmetic pigment and nanoparticle material may range from about 0.01 to about 2.0. In one embodiment of the invention, the difference between the refractive indices of the cosmetic pigment and nanoparticle material is about 2.0. In another embodiment of the invention, the difference between the refractive indices of the cosmetic pigment and nanoparticle material is about 1.0. In another embodiment of the invention, the difference between the refractive indices of the cosmetic pigment and nanoparticle material is about 0.7. In another embodiment of the invention, the difference between the refractive indices of the cosmetic pigment and nanoparticle material is about 0.5.
- compositions comprising a pigment having a high refractive index along with nanoparticles having a low refractive index permit a change in the direction of light at the surface interface to occur thus enhancing light absorption and diffusion, and reducing light reflection and scattering which results in high coverage along with reduced glossiness, enhanced natural or added color contrast and a blurring effect.
- the refractive index of the cosmetic pigment is about 2.02; in another embodiment of the invention, the refractive index of the pigment is about 2.19.
- Weight ratio of the nanoparticles to the pigment particles in the inventive compositions may range from about 10.0:1.0 to about 1.0:10.0. Weight ratios determine the relative percentage of nanoparticles to the pigment particles, thereby affecting the refractive index of the composition.
- the composition has a weight ratio of nanoparticles to pigment particles of about 4.0:1.0; in another embodiment of the invention, the composition has a weight ration of nanoparticles to pigment particles of about 1.0:4.0; in another embodiment of the invention, the composition has a weight ration of nanoparticles to pigment particles of about 1.0:1.0; in another embodiment of the invention, the composition has a weight ratio of nanoparticles to pigment particles of about 1.0:1.4; in yet another embodiment of the invention, the composition has a weight ratio of nanoparticles to pigment particles of about 1.0:1.8; in another embodiment of the invention, the composition has a weight ratio of nanoparticles to pigment particles of about 1.0:3.0.
- the composition has a weight ratio of nanoparticles to pigment particles of
- the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier may range from about 100.0:1.0 to 1.0:5.0, more preferably from about 100.0:1.0 to about 1.0:1.75, more preferably from about 100.0:1.0 to about 1.05:1.0, more preferably from about 20.0:1.0 to about 1.05:1.0, more preferably from about 10.0:1.0 to about 1.05:1.0, more preferably from about 2.0:1.0 to about 1.05:1.0.
- the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier determines the relative percentage of nanoparticles within the composition that are responsible for creating the optical effects observed in the moth eye, that is, increasing the light absorbance.
- L* a* b* color space also known as CIELAB
- L* indicates lightness and a* and b* are the color directions.
- L* is measured from 0 (black) to 100 (white).
- the values of a* and b* are plotted in the xy coordinate plane such that +a is red, ⁇ a is green, +b is yellow, and ⁇ b is blue.
- the origin (center) of the a* b* plane is achromatic, and an increase in (+/ ⁇ ) a* or (+/ ⁇ ) b* results in an increase of the color chroma.
- the inventive formulations have colored pigments, the formulations have increased color chroma, that is, increased (+/ ⁇ ) a* or (+/ ⁇ ) b* values.
- the inventive formulations When the inventive formulations are black, the formulations have increased light absorption and decreased light reflection, that is, a decreased L* value (i.e., a more intense black).
- Table 1 shows examples of mascara formulations and their respective L* values.
- the mascara formula with the hydrophobic amorphous fumed silica shows the lowest L*.
- the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier is about 1.0:1.0; in another embodiment of the invention, the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier is about 1.4:1.0. In one embodiment of the invention, the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier is about 1.7:1.0; in another embodiment of the invention, the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier is about 2.0:1.0
- Suitable film formers for use in the inventive compositions include, but are not limited to, sulfopolyester resins, polyvinylacetate, polyvinyl alcohol polymers, acrylic resins, silicone acrylate polymers (such as those available from Shin Etsu), polyvinylpyrrolidones, high molecular weight silicones, organosiloxanes, polyurethanes, hydrophobic acrylate copolymers, as well as others known in the art (for example those listed in WO 03/105790, incorporated herein).
- the film former is preferably present from about 0.01 weight % to about 20 weight % of the total weight of the composition.
- the film former is a polymer.
- the film former is silicone acrylate copolymer.
- the composition includes one or more waxes, gums, or mixtures thereof.
- Suitable waxes include hydrocarbon-based waxes, fluoro waxes and/or silicone waxes and can be of plant, mineral, animal and/or synthetic origin.
- the waxes have a melting point of greater than 25° C., preferably greater than 45° C.
- the compositions of the present invention may contain from about 0.1 weight % to about 20 weight % waxes, based upon the total weight of the composition.
- the gums are generally high molecular weight polydimethylsiloxanes (PDMSs), cellulose gums or polysaccharides, and the semi-solid materials are generally hydrocarbon-based compounds, such as, but not limited to, lanolins and derivatives thereof, or alternatively PDMSs.
- the compositions of the present invention may contain from about 0.1 weight % to about 20 weight % gums, based upon the total weight of the composition, typically from about 0.5 weight % to about 10 weight %.
- the surface area of the nanoparticles of the inventive compositions may range from about 20 m 2 /g to about 700 m 2 /g; more preferably about 50 m 2 /g to about 500 m 2 /g; more preferably about 70 m 2 /g to about 400 m 2 /g. Surface area of the nanoparticles governs the multiple scattering of light in the composition.
- compositions of the present invention can be prepared by combining a specific amount of pigment, nanoparticles, and a carrier with already premixed solvents, one or more film-formers and/or waxes and other desired ingredients.
- the components are to be mixed with very high shear blade mixers for a sufficient period of time to make a homogeneous mixture. It will be recognized that the time and the sequence of adding compounds may vary depending on the components of the desired composition.
- compositions of the present invention provide increased color chroma of the pigment used, regardless of the type of pigment employed. Accordingly, the inventive compositions can provide color chroma from organic pigments that is similar to color chroma of organic lakes. Such compositions would then have the benefit of high color chroma usually associated with organic pigments but with the stability associated with inorganic pigments.
- the inventive compositions In situations where the inventive compositions lack a pigment it is believed that the compositions will increase light transmission and provide increased color chroma of a biological surface to which the compositions are applied. Such inventive compositions are useful for enhancing the natural color of a biological surface.
- the weight ratio of nanoparticles to film former and/or wax present in the carrier may range from about 100.0:1.0 to 1.0:5.0, more preferably from about 20.0:1.0 to about 1.05:1.0, more preferably from about 10.0:1.0 to about 1.05:1.0, more preferably from about 2.0:1.0 to about 1.05:1.0.
- the light enters the crevices between conical protrusions that are less than 500 nm in diameter ( FIG. 1 ).
- the inventive compositions may contain nanoparticles having a low refractive index; the inventive compositions have nanoparticles that are preferably of sub-visible light wavelength size to create the optical effects observed in the moth eye.
- the nanoparticles aggregate on the layer's outer surface (that is, the surface opposite to the surface adjacent to the biological surface). If such aggregation occurs, then the layer's outer surface would have a morphology similar to that of a moth's eye.
- the nanoparticle aggregation on the layer's outer surface would be dependent on the weight ratio of nanoparticles plus pigment to film former in the carrier.
- the nanoparticles of the inventive compositions are exposed to incident light. It is believed that when incident light strikes the nanoparticles, light is absorbed and scattered which decreases light reflectance.
- Nanoparticles may increase the angle of incidence to greater than the critical angle for total internal reflection, thus enhancing the light diffusion along the interface of nanoparticles and pigment.
- nanoparticles having a low reflective index By using nanoparticles having a low reflective index, one can obtain high coverage along with enhanced color.
- a composition comprising nanoparticles having a low refractive index along with a pigment having a high index of refraction enables the composition to produce a more natural appearance when applied to skin by enhancing transmittance.
- the advantages of the inventive composition include, but are not limited to, the simplicity of providing enhanced color and while employing cosmetically acceptable pigments and carriers.
- nanoparticles in the inventive compositions are small, for example, about 100 nanometers or less, then films and coatings may be produced that, in addition to creating optical effects observed in the moth eye, may also provide ultraviolet (UV) protection.
- UV ultraviolet
- Another advantage of the nanoparticles is that they may absorb oil, sebum, and moisture.
- compositions of the present invention have optical properties which enhance the aesthetic and natural appearance of a biological surface by enhancing the color of the pigments or dyes.
- inventive compositions When applied to a biological surface, the inventive compositions result in optical blurring and increased light transmittance, light scattering and reduced, thereby reducing the appearance of dermatological signs of chronological-aging, photo-aging, hormonal-aging, and/or actinic-aging; reducing the appearance of lines and/or wrinkles; reducing the noticeability of facial lines and wrinkles, facial wrinkles on the cheeks, forehead, perpendicular wrinkles between the eyes, horizontal wrinkles above the eyes, and around the mouth, marionette lines, and particularly deep wrinkles or creases; reducing the appearance and/or depth of lines and/or wrinkles; improving the appearance of suborbital lines and/or periorbital lines; reducing the appearance of crow's feet; improving the appearance of rejuvenating and/or revitalizing skin, decreasing the appearance of aging skin; reducing the appearance of skin fragility; reducing the appearance of
- Another embodiment of the invention relates to a method of improving the aesthetic or natural appearance of a biological surface comprising applying to the biological surface, including but not limited to, keratinous tissue, skin, hair and nails, the inventive composition having the characteristics and properties described herein, in an amount effective to improve the aesthetic or natural appearance of the biological surface.
- the biological surface may be any surface to which cosmetics, personal care products, dermatological, and pharmaceutical compositions are typically applied, including but not limited to skin, lips, hair, nails, and the like.
- the composition that is applied to skin improves or enhances the aesthetic appearance of skin by camouflaging the natural aging process, discoloration, chronic and cumulative damage to biological surfaces, and imperfections on the surface.
- the composition that is applied to keratinous surface or a mucous membrane improves or enhances the aesthetic appearance of the surface by enhancing the natural color and color added in the form of the pigment.
- Embodiments of the invention relate to the discovery that nanoparticles in a composition that produces optical effects observed in the moth eye can camouflage biological surface flaws and add color with increased chroma to the biological surface.
- the optical properties of the inventive compositions enable one to camouflage imperfections of biological surfaces and add colors and shades with increased chroma, thereby improving the aesthetic and natural appearance of biological surfaces.
- the optical properties of the inventive compositions also allow one to beautify and decorate a biological surface.
- compositions preferably have the aforementioned nanoparticles in combination with pigments which improves the cosmetic and/or aesthetic appearance of skin, particularly of aging and/or inflamed skin.
- compositions of the invention are useful in improving the natural and aesthetic appearance of biological surfaces including skin, lips, hair, and nails, when applied, preferably topically as many times as desired by the user to the biological surface.
- compositions of the invention may also include, in addition to a carrier or vehicle, non-limiting examples of active ingredients useful in reducing, diminishing, or camouflaging medical and/or cosmetic conditions associated with aging, inflammation, and degeneration of the biological surface.
- Such conditions commonly include, but are not limited to, dermatological aging (chronological aging, hormonal aging and/or actinic aging), dermatitis, skin and hair fragility, hirsutism, rosacea, skin blemishes, sensitive skin, hyperpigmentation or hypopigmentation, thinning skin, roughness, keratosis, skin atrophy, wrinkles, lines, hyperplasia, fibrosis, and any combinations thereof.
- the active components of the present invention may also be useful in enhancing the general health, vitality, condition, and aesthetic appearance of the skin.
- compositions having the desired properties may be useful in topically applied formulations, anti-oxidants, anti-inflammatories, sunscreens, cosmetics, including makeup, and formulations for reducing dermatological signs of aging, including wrinkles, fine lines, and sagging skin, and the like.
- compositions may be formulated in a variety of product forms.
- the compositions may be prepared in targeted delivery systems, e.g. creams, lotions, moisturizers, gels, toners, serums, sprays, foams, powders, and the like, particularly for topical application and administration.
- inventive compositions are preferably for topical administration or for targeted delivery without inducing significant irritation.
- inventive compositions are suitable for all skin types, such as sensitive, normal, dry, or oily, preferably sensitive to dry skin, as well as mature skin.
- the compositions may be suitable for dry skin.
- the compositions are applied to the skin for a period of time sufficient to enhance the natural and aesthetic appearance of skin.
- the compositions may be applied topically once, twice, or more daily to biological surfaces, including but not limited to skin, lips, and hair.
- compositions may be formulated into liposomes which may comprise other additives or substances, and/or which may be modified to more specifically reach or remain at a site following administration.
- compositions of embodiments of the present invention yield improvements to the aesthetic appearance of skin by camouflaging or improving upon at least one of the previously described conditions, or combinations thereof.
- the inventive compositions may be topically applied as described herein according to the routine technique for administering such compositions.
- the topical cosmetic, dermatological, or pharmaceutical composition preferably is applied once or multiple times daily.
- the cosmetic composition is preferably applied to the face and neck, but may be applied to any area of skin in need of aesthetic improvement, where the cosmetic composition remains on the affected area of skin, and preferably not removed or rinsed off the skin.
- Routine and commonly practiced techniques encompass the application of creams, lotions, gels, sera, ointments, makeup, sunscreen compositions, or the like, to the skin.
- the cosmetic composition is a topical leave on formulation, where spraying as a form of application is also envisioned.
- compositions embraced by this invention can be provided in any cosmetically and/or dermatologically suitable form, preferably as a lotion or cream, but also in an anhydrous or aqueous base, as well as in a sprayable liquid form.
- compositions of this invention include but are not limited to, for example, an emulsion, a cream, a balm, a gloss, a lotion, a foam, a mask, a serum, a toner, an ointment, a mousse, a patch, a pomade, a solution, a spray, a wax-based stick, or a towelette.
- compositions contemplated by this invention can include one or more compatible cosmetically acceptable adjuvants commonly used and known by the skilled practitioner, such as fragrances, emollients, humectants, preservatives, vitamins, chelators, thickeners, perilla oil or perilla seed oil (WO 01/66067 to a “Method of Treating a Skin Condition,” incorporated herewith) and the like, as well as other botanicals such as aloe, chamomile, and the like, and as further described below.
- compatible cosmetically acceptable adjuvants commonly used and known by the skilled practitioner, such as fragrances, emollients, humectants, preservatives, vitamins, chelators, thickeners, perilla oil or perilla seed oil (WO 01/66067 to a “Method of Treating a Skin Condition,” incorporated herewith) and the like, as well as other botanicals such as aloe, chamomile, and the like, and as further described below.
- compositions of this invention may be contained in a cosmetically, dematologically, physiologically, and pharmaceutically acceptable vehicle, medium, diluent or carrier, for use in reducing, ameliorating, or preventing the dermatological signs associated with aging and inflammation of biological surfaces.
- vehicle e.g., a liquid, a solid, a liquid, a solid, a liquid, or a solid, a liquid, or a liquid.
- diluent or carrier e.g., a medium that is compatible with mammalian biological surfaces, including skin, lips, hair and nails.
- compositions can be formulated as an aqueous phase, an oil phase, alcohol, or aqueous/alcohol-based solutions, ointments, creams, lotions, gels, a wax-in-water emulsion, or water-in-oil, oil-in-water, of water-oil-water triple emulsions having the appearance of a cream or gel, microemulsions, or aerosols.
- the aqueous phase is a mixture of one or more water soluble or water dispersible ingredient, which can be liquid, semi-solid or solid at room temperature (25° C.).
- the vehicle comprises or can be in the form of a suspension, dispersion or solution in water or an aqueous-alcoholic vehicle, which may contain a thickener or gellant.
- the composition may include an aqueous phase which may contain water or a mixture of water and at least one hydrophilic organic solvent in particular an alcohol, especially a linear or branched lower monoalcohol containing from 2 to 5 carbon atoms, e.g., ethanol or propanol; a polyol, e.g., propylene glycol, sorbitol, glycerol, diglycerol, panthenol, or polyethylene glycol, and mixtures thereof.
- This aqueous phase may represent from about 0.5 weight % to about 99.99 weight %, based upon the total weight of the composition.
- the composition of the invention when the composition of the invention is in the form of an emulsion, the composition may also optionally comprise a surfactant, preferably in an amount of from about 0.1 weight % to about 30 weight %, and in particular, from about 1 weight % to about 20 weight %, based upon the total weight of the composition.
- a surfactant preferably in an amount of from about 0.1 weight % to about 30 weight %, and in particular, from about 1 weight % to about 20 weight %, based upon the total weight of the composition.
- the composition may also comprise a thickening polymer such as an amphiphilic polyurethane, a polyacrylic homopolymer or copolymer, a polyester, or a hydrocarbon-based resin.
- a thickening polymer such as an amphiphilic polyurethane, a polyacrylic homopolymer or copolymer, a polyester, or a hydrocarbon-based resin.
- Other non-limiting polymers include, homopolymers or copolymers of: vinyl esters of an aliphatic aid having 1 to 18 carbon atoms, such as vinyl acetate; acrylic acid esters and methacrylic acid esters of an alcohol having 1 to 18 carbon atoms, such as methyl acrylate, ethyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, methyl methacrylate, ethyl methacrylate and butyl methacrylate; and mono and di-ethylenically unsaturated hydrocarbons, including
- composition of the invention which may also comprise an oil phase containing oil soluble or oil dispersible ingredients that are liquid at room temperature (25° C.) and/or oily or waxy substances that are solid at room temperature, such as waxes, semi-solids, gums, and mixtures thereof.
- This oily phase may also contain organic solvents.
- oils include hydrocarbon-based oils of animal origin such as perhydrosqualene; hydrocarbon-based plant oils such as liquid triglycerides of fatty acids of 4 to 10 carbon atoms, for instance, heptanoic or octanoic acid triglycerides, or oils such as sunflower oil, corn oil, soybean oil, grapeseed oil, castor oil, avocado oil, caprylic/capric acid triglycerides, jojoba oil; linear or branched hydrocarbons of mineral or synthetic origin such as liquid paraffins and derivatives thereof, petroleum jelly; synthetic esters and ethers, in particular esters of fatty alcohols, namely; for example, isopropyl myristate, 2-ethylhexyl palmitate, 2-octyldodecyl stearate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, oc
- the oil phase of the composition of the invention may also comprise one or more cosmetically acceptable organic solvents. These solvents are present in an amount of about 0.1 weight % to about 80 weight %, preferably about 1 weight % to about 50 weight %, based on the total weight of the composition, and may be selected from the group consisting of lipophilic organic solvents, amphiphilic organic solvents and mixtures thereof.
- Suitable solvents which may be used in the composition of the invention include acetic acid esters such as methyl, ethyl, butyl, amyl or 2-methoxyethyl acetate; isopropyl acetate; hydrocarbons such as toluene, xylene, p-xylene, hexane or heptane; ethers containing at least 3 carbon atoms, and mixtures thereof.
- composition of the invention may further comprise any ingredient conventionally used in the cosmetics field.
- ingredients include preserving agents, aqueous phase thickeners (polysaccharide biopolymers, synthetic polymers) and fatty-phase thickeners, fragrances, hydrophilic and lipophilic active agents, and mixtures thereof.
- the amounts of these various ingredients are those conventionally used in the cosmetics field to achieve their intended purpose, and range typically from about 0.1 weight % to about 20 weight %, based upon the total weight of the composition. The nature of these ingredients and their amounts must be compatible with the production of the compositions of the invention.
- composition of the invention may also comprise an additional particulate phase, typically present in an amount of about 0.1 weight % to about 30 weight %, based upon the total weight of the composition, preferably from about 0.5 weight % to about 20 weight %, and which can comprise pearlescent agents and/or fillers used in cosmetic compositions.
- additional particulate phase typically present in an amount of about 0.1 weight % to about 30 weight %, based upon the total weight of the composition, preferably from about 0.5 weight % to about 20 weight %, and which can comprise pearlescent agents and/or fillers used in cosmetic compositions.
- Suitable pearlescent agents include mica coated with titanium dioxide or with iron oxide.
- Fillers are normally present in an amount of about 0.1 weight % to about 30 weight %, based on the total weight of the composition, preferably about 0.5 weight % to about 15 weight %.
- Suitable fillers include talc, silica, zinc stearate, mica, kaolin, nylon (in particular orgasol) powder, polyethylene powder, Teflon®, starch, boron nitride, copolymer microspheres such as Expancel® (Nobel Industrie; Sweden), Polytrap® (Dow Corning, Inc.; Midland, Mich.), and silicone resin microbeads (Tospearl®; GE Toshiba Silicones; Japan).
- compositions for topical application can be in the form of a protective care composition for the skin, preferably for the face, the neck, the hands, the feet, or other areas of the body.
- a protective care composition for the skin, preferably for the face, the neck, the hands, the feet, or other areas of the body.
- Non-limiting examples include day creams or lotions, night creams or lotions, moisturizer, salves, sunscreen creams, lotions, or oils, ointments, gels, body milks, makeup (a foundation, a bronzer), artificial tanning compositions, depilatories, patches, emulsifiers, or a solid which is poured or cast as a stick or a dish, for example.
- the inventive compositions are ideal for use in a foundation product because it may achieve high camouflage and blurring effects to result in the perception of a natural appearance.
- the topical compositions of the present invention may also include one or more of the following: a skin penetration enhancer, an emollient, a skin plumper, an optical diffuser, a sunscreen, an exfoliation promoter, and an antioxidant.
- a skin penetration enhancer an emollient
- a skin plumper an emollient
- an optical diffuser an emollient
- a sunscreen an exfoliation promoter
- an antioxidant e.g., a sunscreen, an exfoliation promoter, and an antioxidant.
- An emollient provides the functional benefits of enhancing skin smoothness, reducing the appearance of fine lines and coarse wrinkles, and moisturizing.
- Non-limiting examples include isopropyl myristate, petrolatum, isopropyl lanolate, silicones (e.g., methicone, dimethicone), oils, mineral oils, fatty acid esters, or any mixtures thereof.
- the emollient is preferably present from about 0.1 weight % to about 50 weight % of the total weight of the composition.
- a skin plumper serves as a collagen enhancer to the skin.
- An example of a suitable, and preferred, skin plumper is palmitoyl oligopeptide.
- Other skin plumpers are collagen and/or glycosaminoglycan (GAG) enhancing agents.
- the skin plumper is preferably present from about 0.1 weight % to about 20 weight % of the total weight of the composition.
- optical diffusers or soft focus materials that change the surface optical properties of skin, resulting in a visual blurring and softening of, for example, lines and wrinkles are contemplated.
- optical diffusers that can be used in the present invention include, but are not limited to, boron nitride, mica, nylon, polymethylmethacrylate (PMMA), polyurethane powder, sericite, silica, silicone powder, talc, Teflon®, titanium dioxide, zinc oxide, or any mixtures thereof.
- the optical diffuser is preferably present from about 0.01 weight % to about 20 weight % of the total weight of the composition.
- a sunscreen protects the skin from damaging ultraviolet rays.
- the sunscreen would provide both UVA and UVB protection, by using either a single sunscreen or a combination of sunscreens.
- the sunscreens that can be employed in the present compositions are avobenzone, cinnamic acid derivatives (such as octylmethoxy cinnamate), octyl salicylate, oxybenzone, non-mesoporous titanium dioxide, zinc oxide, or any mixtures thereof.
- the sunscreen may be present from about 1 weight % to about 30 weight % of the total weight of the composition.
- the addition of a sunscreen may protect the skin from ultraviolet radiation.
- UV protection may also be achieved by utilizing nanoparticles of about 100 nanometers or less.
- compositions having sunscreen bring about additional improvements to the aesthetic appearance of skin, including at least one of the following: minimizes sunburning, minimizes tanning, and reduces redness.
- compositions may also have one or more exfoliation promoters.
- exfoliation promoters that can be used in the present compositions include alpha hydroxy acids (AHA); benzoyl peroxide; beta hydroxy acids; keto acids, such as pyruvic acid, 2-oxopropanoic acid, 2-oxobutanoic acid, and 2-oxopentanoic acid; oxa acids as disclosed in U.S. Pat. Nos. 5,847,003 and 5,834,513 (the disclosures of which are incorporated herein by reference); salicylic acid; urea; or any mixtures thereof.
- One preferred exfoliation promoters are 3,6,9-trioxaundecanedioic acid, glycolic acid, lactic acid, or any mixtures thereof (See also, INCI at p. 2205).
- the composition has about 0.1 weight % to 30 weight %, preferably about 1 weight % to about 15 weight % and more preferably about 1 weight % to about 10 weight %, of the exfoliation promoter based on the total weight of the composition.
- antioxidants functions, among other things, to scavenge free radicals from skin to protect the skin from environmental aggressors.
- antioxidants that may be used in the present compositions include compounds having phenolic hydroxy functions, such as ascorbic acid and its derivatives/esters; beta-carotene; catechins; curcumin; ferulic acid derivatives (e.g. ethyl ferulate, sodium ferulate); gallic acid derivatives (e.g. propyl gallate); lycopene; reductic acid; rosmarinic acid; tannic acid; tetrahydrocurcumin; tocopherol and its derivatives; uric acid; or any mixtures thereof.
- antioxidants are those that have one or more thiol functions (—SH), in either reduced or non-reduced form, such as glutathione, lipoic acid, thioglycolic acid, and other sulfhydryl compounds.
- the antioxidant may be inorganic, such as bisulfites, metabisulfites, sulfites, or other inorganic salts and acids containing sulfur.
- Compositions of the present invention may have an antioxidant preferably from about 0.001 weight % to about 10 weight %, and more preferably from about 0.01 weight % to about 5 weight %, of the total weight of the composition. (See also, INCI at p. 2184).
- the composition may also have one or more of the following cosmetic and pharmaceutical active agents, excipients, ingredients, or adjuvants: anesthetics, antibiotics, e.g., erythromycins and tetracyclines, salicylic acids, anti-allergenics, antifungals, antiseptics, anti-irritants, anti-inflammatory agents, antimicrobials, analgesics, nitric oxide synthase inhibitors, insect repellents, self-tanning agents, skin penetration enhancers, skin cooling agents, chelating agents, colorants including dyes, lakes and pigments that may be untreated or chemically surface treated to improve wettability or some other property, demulcents, emollients, emulsifiers, fragrances, humectants, lubricants, skin protectants, moisturizers, pH adjusters, preservatives, stabilizers, surfactants, thickeners, plasticizers, viscosity modifiers, vitamins, or any mixture
- Non-limiting examples of active agents for formulating into the compositions of the invention include those reagents having an effect on the treatment of wrinkles and/or fine lines, in addition to the actives as described, such as keratolytic agents, i.e., an active agent having desquamating, exfoliant, or scrubbing properties, or an active agent which can soften the horny layer of the skin.
- keratolytic agents i.e., an active agent having desquamating, exfoliant, or scrubbing properties
- an active agent which can soften the horny layer of the skin include hydroxy acids and retinoids. These agents can be formulated, for example, in amounts of from about 0.01% to 5% by weight relative to the total weight of the composition.
- Suitable hydroxy acids include, for example, glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, 2-hydroxyalkanoic acid, mandelic acid, salicylic acid and alkyl derivatives thereof, including 5-n-octanoylsalicylic acid, 5-n-dodecanoylsalicylic acid, 5-n-decanoylsalicylic acid, 5-n-octylsalicylic acid, 5-n-heptyloxysalicylic acid, 4-n-heptyloxysalicylic acid and 2-hydroxy-3-methylbenzoic acid or alkoxy derivatives thereof, such as 2-hydroxy-3-methyoxybenzoic acid.
- Emulsifiers are typically present in the compositions of the invention in an amount of about 0.01 weight % to 30 weight %, by weight and preferably from about 0.1 weight % to 30 weight % by weight relative to the total weight of the composition. However, not all compositions will necessarily include emulsifiers. (See e.g., INCI at p. 2276-2285).
- Non-limiting examples of suitable thickening agents include xanthan gum, hydroxypropyl cellulose, hydroxyethyl cellulose, carbomer, gum acacia, Sepigel 305 (available from Seppic Co., France), and clays such as magnesium aluminum silicate. (See, e.g., INCI at p. 2293-2299).
- compositions of the present invention may include, and their utility can be enhanced by, one or more humectants, such as ureas, pyrrolidone carboxylic acids, amino acids, sodium hyaluronates, certain polyols and other compounds with hygroscopic properties. (See INCI at p. 2244).
- humectants such as ureas, pyrrolidone carboxylic acids, amino acids, sodium hyaluronates, certain polyols and other compounds with hygroscopic properties.
- the general activity and mildness to skin of the present topical compositions can also be enhanced by neutralization to pH about 3.5 to about 7.0, most preferably from pH about 3.7 to about 5.6.
- This neutralization is preferably accomplished with one or more of ammonium hydroxide, potassium hydroxide, sodium hydroxide, arginine or other amino acids, and/or triethanolamine.
- retinoids include, without limitation, retinoic acid (e.g., all-trans or 13-cis) and derivatives thereof, retinol (Vitamin A) and esters thereof, such as retinol palmitate, retinol acetate and retinol propionate, and salts thereof.
- retinoic acid e.g., all-trans or 13-cis
- retinol Vitamin A
- esters thereof such as retinol palmitate, retinol acetate and retinol propionate, and salts thereof.
- the nanoparticles and pigment of the present invention may be contained in a cosmetically or dermatologically acceptable vehicle, medium, diluent or carrier.
- inventive compositions may be further formulated according to procedures known in the art to provide cosmetic compositions such as emulsions, gels, creams, lotions, masks, toners, serums, oils, water-in-oil, oil-in-water, water-oil-water triple emulsions having the appearance of a cream or gel, microemulsions, ointments, pastes, sticks, cakes, pencils, aerosol, and essences, as well as other topical cosmetic vehicles.
- topical compositions of the present invention can be incorporated into delivery systems such as liposomes and topical patches, tapes, and sprays.
- compositions may be in the form of vesicular dispersions containing ionic and/or nonionic lipids, as described above. Dosage units suitable for such compositions are formulated according to the conventional knowledge and techniques used in the art.
- This example examines the effect of adding nanoparticles to a composition comprising a color pigment in the concentration enough to effectively create optical effects observed in the moth eye.
- compositions comprising nanoparticles were prepared using a speed mixer with silicone acrylate copolymer (KP 550 from Shin Etsu)—which is 40% polymer in isododecane (IDD). Solutions were cast on clean (optically transparent/colorless) glass plates to give a wet film thickness of approximately 125 microns and dried overnight to form dry films with a resulting dry film thickness of 21-25 microns based on solid content. Samples were prepared in duplicate. Average luminescence (L*) was collected directly using the same sample area for total reflection (specular component included—SCI) and scattered reflection (specular component excluded—SCE). Data was collected in two distinct areas for each sample, resulting in four data points per sample.
- SCI surface acrylate copolymer
- SCE scattered reflection
- FIG. 2 shows the reflectance (total reflection (SCI) and scattering reflection (SCE)) of compositions 1, 2, 3, and 4 (control) which were prepared as shown in Table 2.
- SCI total reflection
- SCE scattering reflection
- FIG. 3 shows the absorbance of compositions 1, 2, 3, and 4 (control) which were prepared as shown in Table 2. The figure shows that the addition of silica of any kind increases absorption as compared to a pigment alone (composition 4).
- FIG. 4 shows the reflectance (total reflection (SCI) and scattering reflection (SCE)) of compositions 5, 6, 9, 11, and 4 (control) which were prepared as shown in Table 2.
- SCI total reflection
- SCE scattering reflection
- FIG. 5 shows the absorbance of compositions 5, 6, 9, 11, and 4 (control) which were prepared as shown in Table 2. The figure shows that the addition of fumed silica to carbon black causes a decrease in total reflection.
- Table 3 summarizes the reflectance and absorbance of all compositions which were prepared as shown in Table 2.
- FIGS. 2-5 show that while the efficiency of color chroma and reduction of glossiness is dependent on the nanoparticle loading (wt %) and is effective for the types of silica tested, the greatest increase in absorbance was obtained when the silica (nanoparticle) to carbon-black (pigment) ratio is approximately 1.0:1.4.
- Table 4 lists properties of three batches of compositions of this invention with fumed silica (Degussa Aeroxide LE 3, fumed silica) nanoparticles along with a control batch without any nanoparticles (the full compositions of which are disclosed in Table 2).
- Table 4 shows that the presence of nanoparticles in a composition enhances the absorbance.
- Table 4 shows that as the weight ratio of nanoparticles plus pigment to film former increases, the percent total reflectance decreases.
- FIG. 6 a shows the absorbance for three (3) systems: 4.00% carbon black control with no nanoparticles (batch 14), 4.00% carbon black with 4.00% silica shell nanoparticles (batch 15), and 4.00% carbon black with 4.00% fumed silica nanoparticles (batch 16) which were prepared as shown in Table 5.
- FIG. 6 b shows the luminescence (L*) data for the three systems in FIG. 6 a .
- the figures shows that the addition of either 4.00% fumed silica nanoparticles or 4.00% silica shell nanoparticles results in increased absorbance and reduced luminescence resulting in enhanced contrast (darker) in comparison to the carbon black control (no nanoparticles).
- compositions comprising nanoparticles Carbon Degussa Black, Hydrophobic Aeroxide D&C Silica Shells- LE 3 KP-550, Black SH (Kobo Fumed Film IDD, Total Batch # #2 Products) Silica former Solvent (parts) 14 4.00 0 0 7.00 89.00 100 15 4.00 4.00 0 7.00 85.00 100 16 4.00 0 4.00 7.00 85.00 100
- Table 6 summarizes the reflectance and absorbance of all compositions which were prepared as shown in Table 5.
- FIG. 7 a shows the total transmission for three (3) systems: 4.00% carbon black control with no nanoparticles (batch 14), 4.00% carbon black with 4.00% silica shell nanoparticles (batch 15), and 4.00% carbon black with 4.00% fumed silica nanoparticles (batch 16).
- FIG. 7 b shows the total reflectance and scattered reflectance data for the three systems in FIG. 7 a .
- the figures show that addition of 4.00% fumed silica nanoparticles results in increased transmission, reduced total reflectance and reduced scattered reflectance.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
- The present invention generally relates to cosmetic, dermatological, and pharmaceutical compositions and their use. More particularly the present invention relates to cosmetic compositions and their use in improving the appearance of biological surfaces.
- Modern skin care formulations must meet high standards of efficacy, skin compatibility and aesthetic appeal. Consumers are interested in mitigating or delaying the dermatological signs of chronologically-aged, hormonally-aged or photo-aged skin, such as fine lines, wrinkles, drying, and sagging skin, and other conditions due to a progressive degradation of the skin matrix. Consumers are interested in improving the appearance of, for example, skin, lips, nails, and hair by imparting to these biological surfaces a certain color, which would ideally produce an appearance of a uniform, lively, smooth and even surface, with no apparent imperfections. Therefore, there is a need for cosmetics that assist in creating a flawless, long lasting, lively coloring to improve the appearance of the biological surfaces.
- Presently, make-up compositions that are applied to biological surfaces to impart a certain color such as foundations, face powders, eyeshadows, lipsticks, concealers, blushers, mascaras, eyeliners, lip pencils, eye pencils, or nail varnishes have difficulty achieving a perfect, flawless lively color because cosmetic ingredients such as coloring agents, which provide the desired color and coverage, generally have many limitations.
- The coloring agents employed in such make-up compositions can be lakes, inorganic or organic pigments and/or pearlescent pigments, and alternatively dyes. Inorganic pigments, and in particular inorganic oxides, have the advantage of being relatively stable, but have the drawback of imparting rather dull, pale colors to the material being colored. Organic lakes have the advantage of imparting lively colors to the compositions, but are relatively unstable with respect to light, temperature or pH. Some of these coloring agents also have the drawback of leaving unsightly marks on the skin or the nails after application. Pearlescent pigments allow varied, but not intense, colors to be obtained with iridescent effects. Moreover, certain coloring agents have the drawback of generating free radicals in make-up formulations, which modify the color of the applied make-up and the stability of the compositions. Free radicals, when present on the skin promote ageing of the skin such as the appearance of wrinkles, fine lines and yellowing of the skin.
- Therefore, there remains a need for cosmetic formulations and preparations that provide the increased color chroma of organic lakes while having the stability of inorganic pigments.
- The compound eyes of insects are composed of ommatidia. The ommatidia have smooth surfaces, but some, such as those of moths and butterflies, are covered with tiny, slightly tapered protuberances. These structures are approximately 200 nanometers in both height and diameter at their base, and are arrayed across the surface of the ommatidia in a regular hexagonal pattern. These structures were first observed in nocturnal moths by W. H. Miller and colleagues in 1962 (Bernhard C. G. and Miller W. H. “A corneal nipple pattern in insect compound eyes,” Acta Physiol. Scand. 1962; 56:385-386). Such structures are shown and described in Vukusic, et al., Nature 2003, 424:852-856, for example,
FIG. 7 . - Because the species that possess these structures tend to be active at night or in the dark, it is important that they absorb as much of the available light as possible. The function of such protuberances seems to be to reduce reflection of light from the surface of the ommatidia and thereby increase light's absorption by the receptor cells underneath. Like much of the exoskeleton of insects, the surface of each ommatidium is made of chitin, which has a refractive index (1.55) higher than that of air (1.00).
- The protuberances work by providing a gradual transition in refractive index from air to ommatidium. Each individual photon that is incident on the ommatidia first encounters the thinner tops of the protuberances, making the effective refractive index only slightly higher than the refractive index of air. As the protuberance widens closer to the bottom, the refractive index of the surface approaches that of pure chitin. Because the size and periodicity of the protuberances are smaller than those of the optical wavelengths absorbed (<˜500 nm), each individual photon encounters this gradual transition, and reflection from the surface is minimized. This is known as the “moth-eye principle” or the “moth-eye effect”.
- The moth-eye structure is well suited for many antireflective tasks. In the present application, the inventive cosmetic formulations permit increased light absorption and provide increased color chroma while being relatively stable.
- It is an object of the present invention to provide a composition that delivers in an acceptable carrier comprising a film former and/or wax, an effective amount of a nanoparticle material and one or more pigments sufficient to alter the appearance of a biological surface, where the composition controls light transmission, absorption and scattering. It is a further object to provide cosmetic formulations that provide high color chroma. When the inventive formulations are black, it is a further object permit increased light transmission and absorption and reduced light reflection.
- It is another object of the present invention to provide a method of making a composition of nanoparticle material and pigment in acceptable vehicle or carrier.
- A further object of the invention is to provide a composition comprising an effective amount of nanoparticles to produce the optical effects observed in the moth eye along with one or more pigments in a carrier which further produce unique optical effects on skin. In yet another object, a method of improving the aesthetic or natural appearance of a biological surface by applying to the biological surface a composition comprising an effective amount of nanoparticles to produce optical effects observed in the moth eye and one or more pigments in a carrier in an amount effective to improve the aesthetic or natural appearance of the biological surface. The composition is applied such that the appearance of dermatological signs of damaged or chronologically-aged, hormonally-aged, or photo-aged skin, such as fine lines, wrinkles, and sagging skin, surface imperfections, and discoloration is diminished.
- It is another object of the present invention to provide a method of beautifying and decorating a biological surface by applying to the biological surface a composition comprising a carrier having a film former and/or wax with an effective amount of nanoparticles and one or more pigments to produce the optical effects observed in the moth eye. The composition is applied to a biological surface to add color, hide surface flaws, act as a photoprotectant, and make the surface appear smoother.
- These and other objects and advantages of the present invention, and equivalents thereof, are achieved by compositions having an effective amount of nanoparticles along with pigments and combinations thereof, and methods of using such compositions for topical application in order to improve the aesthetic appearance of a biological surface.
-
FIG. 1 shows a schematic representation of the anti-reflective “moth-eye” surface with the size of the moth-eye structure between 180 nm and 240 nm. This sub-visible light wavelength surface relief profile is a low reflectance interface for light. As a result, the moth's eye appears black and may absorb light from any direction. -
FIG. 2 shows the reflectance (total reflection (SCI) and scattering reflection (SCE)) of four systems: (1) 6.94% carbon black plus 2.78% hydrophobic silica; (2) 6.94% carbon black plus 2.78% hydrophobic fumed silica; (3) 6.94% carbon black plus 2.78% fumed silica and (4) 7.14% carbon black. The full composition of each system is disclosed in Table 2. The figure shows that the addition of silica of any kind reduces total reflection (SCI—specular component included). -
FIG. 3 shows absorbance of the four (4) systems used inFIG. 2 . The figure shows that the addition of silica of any kind increases absorption. The reflection and absorption values for each system disclosed in Table 2 are shown in Table 3. -
FIG. 4 shows the reflectance (total reflection (SCI) and scattering reflection (SCE)) of five systems: (5) 6.94% carbon black plus 5.00% fumed silica; (6) 6.94% carbon black plus 7.00% fumed silica; (9) 9.00% carbon black plus 2.78% fumed silica; (11) 9.00% carbon black plus 5.00% fumed silica; and (4) 7.14% carbon black. (The full composition of each system is disclosed in Table 2). The figure shows that the addition of fumed silica to carbon black causes a decrease in total reflection. -
FIG. 5 shows absorbance of the five systems used inFIG. 4 . The figure shows that the addition of fumed silica to carbon black increases absorption. -
FIG. 6 a shows the absorbance andFIG. 6 b shows the luminescence (L*) data for three (3) systems: 4.00% carbon black control with no nanoparticles, 4.00% carbon black with 4% silica shell nanoparticles, and 4.00% carbon black with 4.00% fumed silica nanoparticles. The figures shows that the addition of either 4.00% fumed silica nanoparticles or 4.00% silica shell nanoparticles results in increased absorbance and reduced luminescence resulting in enhanced contrast (darker) in comparison to the carbon black control (no nanoparticles). The full composition of each system is disclosed in Table 5. -
FIG. 7 a shows the total transmission andFIG. 7 b shows the total reflectance and scattered reflectance data for three (3) systems: 4.00% carbon black control with no nanoparticles, 4.00% carbon black with 4.00% silica shell nanoparticles, and 4.00% carbon black with 4.00% fumed silica nanoparticles. The figures show that addition of 4.00% fumed silica nanoparticles results in increased transmission, reduced total reflectance and reduced scattered reflectance. The full composition of each system is disclosed in Table 5. The reflection and absorption values for each system disclosed in Table 5 are shown in Table 6. - In accordance with the foregoing objectives and others detailed herein, the invention provides compositions comprising an effective amount of nanoparticles in combination with a pigment in an acceptable vehicle having a film former and/or wax to create optical effects observed in the moth eye which improve the aesthetic appearance of biological surfaces. The compositions, for example, improve the appearance of biological surfaces damaged by the chronological aging process, the environment, or natural imperfections. The compositions also serve to beautify and decorate the biological surfaces. When applied to a surface, for example, a biological surface, the compositions enhance the appearance of the surface by enhancing absorbance, enhancing transmittance and reducing reflective properties. Enhancing the aesthetic appearance of the biological surfaces may be achieved by topical application of the inventive compositions to the biological surfaces on a daily basis or when a natural appearance or added color is desired. Biological surfaces include, but are not limited to, keratinous tissues, skin, hair, lips, eyelashes, eyebrows and nails.
- The compositions of the invention alter the manner in which light reaches a biological surface so as to provide hiding, opacity, and coverage. The inventive compositions comprise transparent or translucent nanoparticles along with a cosmetic pigment. The nanoparticles in combination with pigment present in a cosmetic composition are suitable for application to biological surfaces.
- The term “nanoparticle” as used herein refers to a nanometer-sized particle, having a diameter of between about 1 nanometer and about 999 nanometers; the term “nanoparticles” as used herein refers to nanometer-sized particles, nanoclusters, clusters, particles, small particles, and nanostructured materials.
- An effective amount of nanoparticle material in an acceptable carrier depends on factors including the weight ratio of nanoparticles plus pigment to film former and/or wax in the carrier, the surface area of each nanoparticle, the physical properties of the nanoparticles and the weight ratio of nanoparticles to the pigment. The pigment, carrier and nanoparticle material may each have a different refractive index so as to control light diffusion properties. The refractive index of the pigment is greater than the nanoparticle material to obtain optimal lateral light diffusion. The size of each nanoparticle is preferably less than the wavelength of visible light to enhance light absorption and reduce reflectance.
- Pigments suitable in this invention range in particle size from about 100 nanometers to about 10 microns. More preferably, pigment particle sizes range from about 100 nanometers to about 2 microns. Preferred inorganic pigments for use in this invention are those typically used in the personal care or cosmetic industry to provide hiding, coverage and/or color. In one embodiment of the invention, the pigment material is about 0.5 microns; in another embodiment of the invention, pigment material is about 1.0 microns. Reference to the size of a pigment or nanoparticle means the length of the largest straight dimension of the pigment or nanoparticle. By way of example, the size of a spherical pigment is its diameter, and the size of a spherical nanoparticle is its diameter.
- The refractive index of the pigments can be from about 1.38 to about 3.52; more preferably about 1.40 to about 3.50; more preferably about 1.42 to about 3.40; more preferably about 1.60 to about 3.40. Pigments having refractive indices of about 1.38 to about 3.52 include, but are not limited to, titanium dioxide (rutile or anatase), zinc oxide and iron oxide. The refractive indices of various materials may be evaluated using a refractometer. Details with respect to the principles of refraction can be found in Optics by Eugene Hecht (Fourth Edition), 2002. Details with respect to refractive indices of materials can be found in the CRC Handbook of Chemistry and Physics, 86th Edition, 2005-2006, which is herein incorporated by reference in its entirety.
- In one embodiment, the composition is comprised of a combination of pigments of different refractive indices. In another embodiment of the invention, the composition is comprised of a single pigment.
- Suitable inorganic pigments include, but are not limited to, titanium dioxide, zirconium oxide and cerium oxide, as well as zinc oxide, iron oxide, chromium oxide and ferric blue. Suitable organic pigments include, but are not limited to, barium, strontium, calcium, and aluminum lakes and carbon black. Any pigment material of the inventive composition producing the desired effects may be used, non-limiting examples of which include a metal oxide, for example, titanium dioxide, iron oxide, and aluminum oxide. For typical pigments used in cosmetic industry, refer to the Cosmetic Ingredient Dictionary (INCI) and Handbook, 10th Edition (2004), published by the Cosmetic, Toiletry, and Fragrance Association (CTFA).
- In one embodiment, the composition comprises titanium dioxide. In another embodiment, the composition comprises iron oxide. In another embodiment, the composition comprises carbon black.
- Organic and inorganic pigments suitable for use in this invention may be substantially solid or porous. In one embodiment, the outer surface of the pigment is substantially solid and of uniform contour.
- Nanoparticles suitable to create the desired optical effects observed in the moth eye of this invention range in size from about 1 nm to about 900 nm; more preferably from about 7 nm to about 700 nm; more preferably from about 10 nm to about 500 nm. Mean particle sizes of nanoparticles of this invention range in size from about 10 nm to about 700 nm; more preferably from about 20 nm to about 500 nm; more preferably from about 30 nm to about 500 nm. In various embodiments of the invention, the mean particle size of the nanoparticles may be about 10 nm, about 20 nm, about 50 nm, about 75 nm, about 100 nm, about 125 nm, about 150 nm, about 175 nm, about 200 nm, about 225 nm, about 250 nm, about 275 nm, about 300 nm, about 325 nm, about 350 nm, about 375 nm, about 400 nm, about 425 nm, about 450 nm, about 475 nm, or about 500 nm. Preferably, the nanoparticles have a diameter below the wavelength of light they are interacting with, thereby producing the desired effects.
- In one embodiment of the invention, the nanoparticles are smaller than the size of the pigment. In another embodiment of the invention, the nanoparticles are about the same size as the pigment. In yet another embodiment of the invention, the nanoparticles are larger than the size of the pigment.
- Nanoparticles suitable for this invention include, but are not limited to, nanoparticles made of fumed silica, metal oxides such as aluminum oxide, fumed alumina, zinc oxide, titanium dioxide or zirconium oxide, or polymeric nanoparticles such as poly(methyl methacrylate) (PMMA), nylon, polyethylene (PE), polystyrene (PS), polytetrafluoroethylene, or cellulosics. The refractive index of the nanoparticles can be from about 1.30 to about 3.50. In one embodiment of the invention, the nanoparticle is fumed silica having a refractive index of about 1.46. In one embodiment, the composition is comprised of a combination of nanoparticles of different refractive indices.
- The nanoparticles in the composition are capable of enhancing the absorption and/or altering the scattering behavior of visible light. The difference between the refractive indices of the cosmetic pigment and nanoparticle material may range from about 0.01 to about 2.0. In one embodiment of the invention, the difference between the refractive indices of the cosmetic pigment and nanoparticle material is about 2.0. In another embodiment of the invention, the difference between the refractive indices of the cosmetic pigment and nanoparticle material is about 1.0. In another embodiment of the invention, the difference between the refractive indices of the cosmetic pigment and nanoparticle material is about 0.7. In another embodiment of the invention, the difference between the refractive indices of the cosmetic pigment and nanoparticle material is about 0.5.
- Compositions comprising a pigment having a high refractive index along with nanoparticles having a low refractive index permit a change in the direction of light at the surface interface to occur thus enhancing light absorption and diffusion, and reducing light reflection and scattering which results in high coverage along with reduced glossiness, enhanced natural or added color contrast and a blurring effect. In one embodiment of the invention, the refractive index of the cosmetic pigment is about 2.02; in another embodiment of the invention, the refractive index of the pigment is about 2.19.
- Weight ratio of the nanoparticles to the pigment particles in the inventive compositions may range from about 10.0:1.0 to about 1.0:10.0. Weight ratios determine the relative percentage of nanoparticles to the pigment particles, thereby affecting the refractive index of the composition. In one embodiment of the invention, the composition has a weight ratio of nanoparticles to pigment particles of about 4.0:1.0; in another embodiment of the invention, the composition has a weight ration of nanoparticles to pigment particles of about 1.0:4.0; in another embodiment of the invention, the composition has a weight ration of nanoparticles to pigment particles of about 1.0:1.0; in another embodiment of the invention, the composition has a weight ratio of nanoparticles to pigment particles of about 1.0:1.4; in yet another embodiment of the invention, the composition has a weight ratio of nanoparticles to pigment particles of about 1.0:1.8; in another embodiment of the invention, the composition has a weight ratio of nanoparticles to pigment particles of about 1.0:3.0. In a preferred embodiment of the invention the composition has a weight ratio of nanoparticles to pigment particles of about 1.0:1.4.
- The weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier may range from about 100.0:1.0 to 1.0:5.0, more preferably from about 100.0:1.0 to about 1.0:1.75, more preferably from about 100.0:1.0 to about 1.05:1.0, more preferably from about 20.0:1.0 to about 1.05:1.0, more preferably from about 10.0:1.0 to about 1.05:1.0, more preferably from about 2.0:1.0 to about 1.05:1.0. The weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier determines the relative percentage of nanoparticles within the composition that are responsible for creating the optical effects observed in the moth eye, that is, increasing the light absorbance.
- In the L* a* b* color space (also known as CIELAB), L* indicates lightness and a* and b* are the color directions. L* is measured from 0 (black) to 100 (white). The values of a* and b* are plotted in the xy coordinate plane such that +a is red, −a is green, +b is yellow, and −b is blue. The origin (center) of the a* b* plane is achromatic, and an increase in (+/−) a* or (+/−) b* results in an increase of the color chroma. When the inventive formulations have colored pigments, the formulations have increased color chroma, that is, increased (+/−) a* or (+/−) b* values. When the inventive formulations are black, the formulations have increased light absorption and decreased light reflection, that is, a decreased L* value (i.e., a more intense black). Table 1 shows examples of mascara formulations and their respective L* values. The mascara formula with the hydrophobic amorphous fumed silica shows the lowest L*.
-
TABLE 1 Examples of mascara formulations demonstrating their respective L* values 1 2 3 Kobo Black iron oxide pigment 4.00 4.00 4.00 Aeroxide LE 3 (deGussa) 0 4.00 0 Cadre Hydrophobic Amorphous Fumed 4.00 0 0 Silica # 79684 KP-550 (Shin Etsu) 5.60 5.60 5.60 Versagel MD 1600 (Panerco) 56.00 56.00 56.00 Isododecane 30.40 30.40 30.40 (TOTAL) 100 100 100 L* Value 15.40 19.00 25.00 - In one embodiment of the invention, the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier is about 1.0:1.0; in another embodiment of the invention, the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier is about 1.4:1.0. In one embodiment of the invention, the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier is about 1.7:1.0; in another embodiment of the invention, the weight ratio of nanoparticles plus pigment particles to film former and/or wax present in the carrier is about 2.0:1.0
- Suitable film formers for use in the inventive compositions include, but are not limited to, sulfopolyester resins, polyvinylacetate, polyvinyl alcohol polymers, acrylic resins, silicone acrylate polymers (such as those available from Shin Etsu), polyvinylpyrrolidones, high molecular weight silicones, organosiloxanes, polyurethanes, hydrophobic acrylate copolymers, as well as others known in the art (for example those listed in WO 03/105790, incorporated herein). The film former is preferably present from about 0.01 weight % to about 20 weight % of the total weight of the composition. In one embodiment, the film former is a polymer. In one embodiment, the film former is silicone acrylate copolymer.
- In one embodiment of the invention, the composition includes one or more waxes, gums, or mixtures thereof. Suitable waxes include hydrocarbon-based waxes, fluoro waxes and/or silicone waxes and can be of plant, mineral, animal and/or synthetic origin. In particular, the waxes have a melting point of greater than 25° C., preferably greater than 45° C. The compositions of the present invention may contain from about 0.1 weight % to about 20 weight % waxes, based upon the total weight of the composition. The gums are generally high molecular weight polydimethylsiloxanes (PDMSs), cellulose gums or polysaccharides, and the semi-solid materials are generally hydrocarbon-based compounds, such as, but not limited to, lanolins and derivatives thereof, or alternatively PDMSs. The compositions of the present invention may contain from about 0.1 weight % to about 20 weight % gums, based upon the total weight of the composition, typically from about 0.5 weight % to about 10 weight %.
- The surface area of the nanoparticles of the inventive compositions may range from about 20 m2/g to about 700 m2/g; more preferably about 50 m2/g to about 500 m2/g; more preferably about 70 m2/g to about 400 m2/g. Surface area of the nanoparticles governs the multiple scattering of light in the composition.
- The compositions of the present invention can be prepared by combining a specific amount of pigment, nanoparticles, and a carrier with already premixed solvents, one or more film-formers and/or waxes and other desired ingredients. The components are to be mixed with very high shear blade mixers for a sufficient period of time to make a homogeneous mixture. It will be recognized that the time and the sequence of adding compounds may vary depending on the components of the desired composition.
- The compositions of the present invention provide increased color chroma of the pigment used, regardless of the type of pigment employed. Accordingly, the inventive compositions can provide color chroma from organic pigments that is similar to color chroma of organic lakes. Such compositions would then have the benefit of high color chroma usually associated with organic pigments but with the stability associated with inorganic pigments.
- In situations where the inventive compositions lack a pigment it is believed that the compositions will increase light transmission and provide increased color chroma of a biological surface to which the compositions are applied. Such inventive compositions are useful for enhancing the natural color of a biological surface. In situations where the inventive composition lacks a pigment, the weight ratio of nanoparticles to film former and/or wax present in the carrier may range from about 100.0:1.0 to 1.0:5.0, more preferably from about 20.0:1.0 to about 1.05:1.0, more preferably from about 10.0:1.0 to about 1.05:1.0, more preferably from about 2.0:1.0 to about 1.05:1.0.
- In the moth's eye, the light enters the crevices between conical protrusions that are less than 500 nm in diameter (
FIG. 1 ). The inventive compositions may contain nanoparticles having a low refractive index; the inventive compositions have nanoparticles that are preferably of sub-visible light wavelength size to create the optical effects observed in the moth eye. - Without wishing to be bound by any particular theory or mechanism, it is believed that when a composition of the invention is applied as a layer to a biological surface, the nanoparticles aggregate on the layer's outer surface (that is, the surface opposite to the surface adjacent to the biological surface). If such aggregation occurs, then the layer's outer surface would have a morphology similar to that of a moth's eye. The nanoparticle aggregation on the layer's outer surface would be dependent on the weight ratio of nanoparticles plus pigment to film former in the carrier. At specific weight ratios disclosed herein, the nanoparticles of the inventive compositions are exposed to incident light. It is believed that when incident light strikes the nanoparticles, light is absorbed and scattered which decreases light reflectance.
- Design and choice of nanoparticles may increase the angle of incidence to greater than the critical angle for total internal reflection, thus enhancing the light diffusion along the interface of nanoparticles and pigment. By using nanoparticles having a low reflective index, one can obtain high coverage along with enhanced color. A composition comprising nanoparticles having a low refractive index along with a pigment having a high index of refraction enables the composition to produce a more natural appearance when applied to skin by enhancing transmittance.
- The advantages of the inventive composition include, but are not limited to, the simplicity of providing enhanced color and while employing cosmetically acceptable pigments and carriers.
- If the nanoparticles in the inventive compositions are small, for example, about 100 nanometers or less, then films and coatings may be produced that, in addition to creating optical effects observed in the moth eye, may also provide ultraviolet (UV) protection. Another advantage of the nanoparticles is that they may absorb oil, sebum, and moisture. These properties provide additional benefits in cosmetic and dermatological formulations or compositions, and enhance the aesthetic and natural appearance of biological surfaces.
- Compositions of the present invention have optical properties which enhance the aesthetic and natural appearance of a biological surface by enhancing the color of the pigments or dyes. When applied to a biological surface, the inventive compositions result in optical blurring and increased light transmittance, light scattering and reduced, thereby reducing the appearance of dermatological signs of chronological-aging, photo-aging, hormonal-aging, and/or actinic-aging; reducing the appearance of lines and/or wrinkles; reducing the noticeability of facial lines and wrinkles, facial wrinkles on the cheeks, forehead, perpendicular wrinkles between the eyes, horizontal wrinkles above the eyes, and around the mouth, marionette lines, and particularly deep wrinkles or creases; reducing the appearance and/or depth of lines and/or wrinkles; improving the appearance of suborbital lines and/or periorbital lines; reducing the appearance of crow's feet; improving the appearance of rejuvenating and/or revitalizing skin, decreasing the appearance of aging skin; reducing the appearance of skin fragility; reducing the appearance of a loss of glycosaminoglycans and/or collagen; reducing the appearance of estrogen imbalance; reducing the appearance of skin atrophy; reducing the appearance of hyperpigmentation; reducing the appearance of skin discoloration; improving the appearance of skin tone, radiance, clarity and/or tautness; reducing the appearance of sagging skin; improving the appearance of skin firmness, plumpness, suppleness and/or softness; improving the appearance of procollagen and/or collagen production; improving the appearance of skin texture and/or retexturization; improving the appearance of skin barrier repair and/or function; improving the appearance of skin contours; improving the appearance of decreased skin luster and/or brightness; improving the appearance of dermatological signs of fatigue and/or stress; improving the appearance of environmental stress; improving the appearance of cellular aging; improving the appearance of skin dehydration; improving the appearance of elastic and/or resilient skin; improving the appearance of microcirculation; decreasing the appearance of cellulite formation; or any combinations thereof.
- Another embodiment of the invention relates to a method of improving the aesthetic or natural appearance of a biological surface comprising applying to the biological surface, including but not limited to, keratinous tissue, skin, hair and nails, the inventive composition having the characteristics and properties described herein, in an amount effective to improve the aesthetic or natural appearance of the biological surface.
- The biological surface may be any surface to which cosmetics, personal care products, dermatological, and pharmaceutical compositions are typically applied, including but not limited to skin, lips, hair, nails, and the like. The composition that is applied to skin improves or enhances the aesthetic appearance of skin by camouflaging the natural aging process, discoloration, chronic and cumulative damage to biological surfaces, and imperfections on the surface. The composition that is applied to keratinous surface or a mucous membrane improves or enhances the aesthetic appearance of the surface by enhancing the natural color and color added in the form of the pigment.
- Embodiments of the invention relate to the discovery that nanoparticles in a composition that produces optical effects observed in the moth eye can camouflage biological surface flaws and add color with increased chroma to the biological surface. Thus, the optical properties of the inventive compositions enable one to camouflage imperfections of biological surfaces and add colors and shades with increased chroma, thereby improving the aesthetic and natural appearance of biological surfaces. The optical properties of the inventive compositions also allow one to beautify and decorate a biological surface.
- One embodiment of the invention relates to methods of applying the claimed composition to an affected area of the skin. The composition is preferably applied topically as desired by the user any number of times during the day, and remains on the affected area of the skin, where the affected area of the skin includes, but is not limited to, the face, neck, legs and thighs, scalp, and overall body. Topical compositions preferably have the aforementioned nanoparticles in combination with pigments which improves the cosmetic and/or aesthetic appearance of skin, particularly of aging and/or inflamed skin.
- The inventive compositions are useful in improving the natural and aesthetic appearance of biological surfaces including skin, lips, hair, and nails, when applied, preferably topically as many times as desired by the user to the biological surface. The compositions of the invention may also include, in addition to a carrier or vehicle, non-limiting examples of active ingredients useful in reducing, diminishing, or camouflaging medical and/or cosmetic conditions associated with aging, inflammation, and degeneration of the biological surface. Such conditions, as used herein, commonly include, but are not limited to, dermatological aging (chronological aging, hormonal aging and/or actinic aging), dermatitis, skin and hair fragility, hirsutism, rosacea, skin blemishes, sensitive skin, hyperpigmentation or hypopigmentation, thinning skin, roughness, keratosis, skin atrophy, wrinkles, lines, hyperplasia, fibrosis, and any combinations thereof. The active components of the present invention may also be useful in enhancing the general health, vitality, condition, and aesthetic appearance of the skin.
- In accordance with the invention, compositions having the desired properties may be useful in topically applied formulations, anti-oxidants, anti-inflammatories, sunscreens, cosmetics, including makeup, and formulations for reducing dermatological signs of aging, including wrinkles, fine lines, and sagging skin, and the like. Also in accordance with this invention, compositions may be formulated in a variety of product forms. The compositions may be prepared in targeted delivery systems, e.g. creams, lotions, moisturizers, gels, toners, serums, sprays, foams, powders, and the like, particularly for topical application and administration.
- The inventive compositions are preferably for topical administration or for targeted delivery without inducing significant irritation. The inventive compositions are suitable for all skin types, such as sensitive, normal, dry, or oily, preferably sensitive to dry skin, as well as mature skin. In particular embodiments, the compositions may be suitable for dry skin. The compositions are applied to the skin for a period of time sufficient to enhance the natural and aesthetic appearance of skin. The compositions may be applied topically once, twice, or more daily to biological surfaces, including but not limited to skin, lips, and hair.
- The topical compositions may be formulated into liposomes which may comprise other additives or substances, and/or which may be modified to more specifically reach or remain at a site following administration. The compositions of embodiments of the present invention yield improvements to the aesthetic appearance of skin by camouflaging or improving upon at least one of the previously described conditions, or combinations thereof.
- The inventive compositions may be topically applied as described herein according to the routine technique for administering such compositions. The topical cosmetic, dermatological, or pharmaceutical composition preferably is applied once or multiple times daily. The cosmetic composition is preferably applied to the face and neck, but may be applied to any area of skin in need of aesthetic improvement, where the cosmetic composition remains on the affected area of skin, and preferably not removed or rinsed off the skin. Routine and commonly practiced techniques encompass the application of creams, lotions, gels, sera, ointments, makeup, sunscreen compositions, or the like, to the skin. Preferably the cosmetic composition is a topical leave on formulation, where spraying as a form of application is also envisioned.
- The inventive compositions are suitable for contact with living mammalian tissue, including human tissue, or synthetic equivalents thereof, with virtually no adverse physiological effect to the user. Compositions embraced by this invention can be provided in any cosmetically and/or dermatologically suitable form, preferably as a lotion or cream, but also in an anhydrous or aqueous base, as well as in a sprayable liquid form. Other suitable cosmetic product forms for the compositions of this invention include but are not limited to, for example, an emulsion, a cream, a balm, a gloss, a lotion, a foam, a mask, a serum, a toner, an ointment, a mousse, a patch, a pomade, a solution, a spray, a wax-based stick, or a towelette. In addition, the compositions contemplated by this invention can include one or more compatible cosmetically acceptable adjuvants commonly used and known by the skilled practitioner, such as fragrances, emollients, humectants, preservatives, vitamins, chelators, thickeners, perilla oil or perilla seed oil (WO 01/66067 to a “Method of Treating a Skin Condition,” incorporated herewith) and the like, as well as other botanicals such as aloe, chamomile, and the like, and as further described below.
- The nanoparticles in combination with pigment of the present invention may be contained in a cosmetically, dematologically, physiologically, and pharmaceutically acceptable vehicle, medium, diluent or carrier, for use in reducing, ameliorating, or preventing the dermatological signs associated with aging and inflammation of biological surfaces. In an embodiment embracing topical applications, the compositions of this invention comprise a medium (vehicle, diluent or carrier) that is compatible with mammalian biological surfaces, including skin, lips, hair and nails. The compositions can be formulated as an aqueous phase, an oil phase, alcohol, or aqueous/alcohol-based solutions, ointments, creams, lotions, gels, a wax-in-water emulsion, or water-in-oil, oil-in-water, of water-oil-water triple emulsions having the appearance of a cream or gel, microemulsions, or aerosols.
- The aqueous phase is a mixture of one or more water soluble or water dispersible ingredient, which can be liquid, semi-solid or solid at room temperature (25° C.). The vehicle comprises or can be in the form of a suspension, dispersion or solution in water or an aqueous-alcoholic vehicle, which may contain a thickener or gellant. A person skilled in the art can select the appropriate cosmetic form, the ingredients contained therein, as well as the method for preparing it, on the basis of the knowledge that the skilled artisan possesses.
- In one embodiment, the composition may include an aqueous phase which may contain water or a mixture of water and at least one hydrophilic organic solvent in particular an alcohol, especially a linear or branched lower monoalcohol containing from 2 to 5 carbon atoms, e.g., ethanol or propanol; a polyol, e.g., propylene glycol, sorbitol, glycerol, diglycerol, panthenol, or polyethylene glycol, and mixtures thereof. This aqueous phase may represent from about 0.5 weight % to about 99.99 weight %, based upon the total weight of the composition.
- In another embodiment when the composition of the invention is in the form of an emulsion, the composition may also optionally comprise a surfactant, preferably in an amount of from about 0.1 weight % to about 30 weight %, and in particular, from about 1 weight % to about 20 weight %, based upon the total weight of the composition.
- In a further embodiment of the invention, the composition may also comprise a thickening polymer such as an amphiphilic polyurethane, a polyacrylic homopolymer or copolymer, a polyester, or a hydrocarbon-based resin. Other non-limiting polymers include, homopolymers or copolymers of: vinyl esters of an aliphatic aid having 1 to 18 carbon atoms, such as vinyl acetate; acrylic acid esters and methacrylic acid esters of an alcohol having 1 to 18 carbon atoms, such as methyl acrylate, ethyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, methyl methacrylate, ethyl methacrylate and butyl methacrylate; and mono and di-ethylenically unsaturated hydrocarbons, including ethylene iso-butylene, styrene and aliphatic dunes, including butadiene, isoprene and chloroprene.
- One embodiment of the invention further relates to a composition of the invention which may also comprise an oil phase containing oil soluble or oil dispersible ingredients that are liquid at room temperature (25° C.) and/or oily or waxy substances that are solid at room temperature, such as waxes, semi-solids, gums, and mixtures thereof. This oily phase may also contain organic solvents.
- Suitable oily materials that are liquid at room temperature, often referred to as oils, include hydrocarbon-based oils of animal origin such as perhydrosqualene; hydrocarbon-based plant oils such as liquid triglycerides of fatty acids of 4 to 10 carbon atoms, for instance, heptanoic or octanoic acid triglycerides, or oils such as sunflower oil, corn oil, soybean oil, grapeseed oil, castor oil, avocado oil, caprylic/capric acid triglycerides, jojoba oil; linear or branched hydrocarbons of mineral or synthetic origin such as liquid paraffins and derivatives thereof, petroleum jelly; synthetic esters and ethers, in particular esters of fatty alcohols, namely; for example, isopropyl myristate, 2-ethylhexyl palmitate, 2-octyldodecyl stearate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, heptanoates, octanoates and decanoates of fatty alcohols; polyol esters such as propylene glycol dioctanoate, neopentyl glycol diheptanoate, diethylene glycol diisononanoate, and pentaerythritol esters; fatty alcohols containing from 12 to 26 carbon atoms such as octyldodecanol, 2-butyloctanol, 2-hexyldecanol, 2-undecylpentadecanol, oleyl alcohol; partially hydrocarbon-based fluoro oils and/or fluorosilicone oils; silicone oils such as volatile or non-volatile, linear or cyclic polydimethylsiloxanes (PDMS) that are liquid or semisolid at room temperature such as cyclomethicones and dimethicones, optionally comprising a phenyl group, for instance phenyl trimethicones, siloxanes, and mixtures thereof. These oils are usually present in an amount of about 0 weight % to about 90 weight %, preferably from about 1 weight % to about 80 weight % by weight of the oil phase.
- The oil phase of the composition of the invention may also comprise one or more cosmetically acceptable organic solvents. These solvents are present in an amount of about 0.1 weight % to about 80 weight %, preferably about 1 weight % to about 50 weight %, based on the total weight of the composition, and may be selected from the group consisting of lipophilic organic solvents, amphiphilic organic solvents and mixtures thereof. Suitable solvents which may be used in the composition of the invention include acetic acid esters such as methyl, ethyl, butyl, amyl or 2-methoxyethyl acetate; isopropyl acetate; hydrocarbons such as toluene, xylene, p-xylene, hexane or heptane; ethers containing at least 3 carbon atoms, and mixtures thereof.
- The composition of the invention may further comprise any ingredient conventionally used in the cosmetics field. These ingredients include preserving agents, aqueous phase thickeners (polysaccharide biopolymers, synthetic polymers) and fatty-phase thickeners, fragrances, hydrophilic and lipophilic active agents, and mixtures thereof. The amounts of these various ingredients are those conventionally used in the cosmetics field to achieve their intended purpose, and range typically from about 0.1 weight % to about 20 weight %, based upon the total weight of the composition. The nature of these ingredients and their amounts must be compatible with the production of the compositions of the invention.
- The composition of the invention may also comprise an additional particulate phase, typically present in an amount of about 0.1 weight % to about 30 weight %, based upon the total weight of the composition, preferably from about 0.5 weight % to about 20 weight %, and which can comprise pearlescent agents and/or fillers used in cosmetic compositions. Suitable pearlescent agents include mica coated with titanium dioxide or with iron oxide.
- Fillers are normally present in an amount of about 0.1 weight % to about 30 weight %, based on the total weight of the composition, preferably about 0.5 weight % to about 15 weight %. Suitable fillers include talc, silica, zinc stearate, mica, kaolin, nylon (in particular orgasol) powder, polyethylene powder, Teflon®, starch, boron nitride, copolymer microspheres such as Expancel® (Nobel Industrie; Sweden), Polytrap® (Dow Corning, Inc.; Midland, Mich.), and silicone resin microbeads (Tospearl®; GE Toshiba Silicones; Japan).
- More particularly, the compositions for topical application can be in the form of a protective care composition for the skin, preferably for the face, the neck, the hands, the feet, or other areas of the body. Non-limiting examples include day creams or lotions, night creams or lotions, moisturizer, salves, sunscreen creams, lotions, or oils, ointments, gels, body milks, makeup (a foundation, a bronzer), artificial tanning compositions, depilatories, patches, emulsifiers, or a solid which is poured or cast as a stick or a dish, for example. The inventive compositions are ideal for use in a foundation product because it may achieve high camouflage and blurring effects to result in the perception of a natural appearance.
- In another embodiment, the topical compositions of the present invention may also include one or more of the following: a skin penetration enhancer, an emollient, a skin plumper, an optical diffuser, a sunscreen, an exfoliation promoter, and an antioxidant. Details with respect to these and other suitable cosmetic ingredients can be found in the International Cosmetic Ingredient Dictionary (INCI) and Handbook, 10th Edition (2004), published by the Cosmetic, Toiletry, and Fragrance Association (CTFA), at pp. 2177-2299, which is herein incorporated by reference in its entirety.
- An emollient provides the functional benefits of enhancing skin smoothness, reducing the appearance of fine lines and coarse wrinkles, and moisturizing. Non-limiting examples include isopropyl myristate, petrolatum, isopropyl lanolate, silicones (e.g., methicone, dimethicone), oils, mineral oils, fatty acid esters, or any mixtures thereof. The emollient is preferably present from about 0.1 weight % to about 50 weight % of the total weight of the composition.
- A skin plumper serves as a collagen enhancer to the skin. An example of a suitable, and preferred, skin plumper is palmitoyl oligopeptide. Other skin plumpers are collagen and/or glycosaminoglycan (GAG) enhancing agents. The skin plumper is preferably present from about 0.1 weight % to about 20 weight % of the total weight of the composition.
- In addition to the nanoparticles and pigment, optical diffusers or soft focus materials that change the surface optical properties of skin, resulting in a visual blurring and softening of, for example, lines and wrinkles are contemplated. Examples of optical diffusers that can be used in the present invention include, but are not limited to, boron nitride, mica, nylon, polymethylmethacrylate (PMMA), polyurethane powder, sericite, silica, silicone powder, talc, Teflon®, titanium dioxide, zinc oxide, or any mixtures thereof. The optical diffuser is preferably present from about 0.01 weight % to about 20 weight % of the total weight of the composition.
- A sunscreen protects the skin from damaging ultraviolet rays. In an illustrative embodiment of the invention, the sunscreen would provide both UVA and UVB protection, by using either a single sunscreen or a combination of sunscreens. Among the sunscreens that can be employed in the present compositions are avobenzone, cinnamic acid derivatives (such as octylmethoxy cinnamate), octyl salicylate, oxybenzone, non-mesoporous titanium dioxide, zinc oxide, or any mixtures thereof. The sunscreen may be present from about 1 weight % to about 30 weight % of the total weight of the composition. The addition of a sunscreen may protect the skin from ultraviolet radiation. As explained above, UV protection may also be achieved by utilizing nanoparticles of about 100 nanometers or less.
- The inventive compositions having sunscreen bring about additional improvements to the aesthetic appearance of skin, including at least one of the following: minimizes sunburning, minimizes tanning, and reduces redness.
- In an embodiment of the invention, compositions may also have one or more exfoliation promoters. Suitable examples of an exfoliation promoter that can be used in the present compositions include alpha hydroxy acids (AHA); benzoyl peroxide; beta hydroxy acids; keto acids, such as pyruvic acid, 2-oxopropanoic acid, 2-oxobutanoic acid, and 2-oxopentanoic acid; oxa acids as disclosed in U.S. Pat. Nos. 5,847,003 and 5,834,513 (the disclosures of which are incorporated herein by reference); salicylic acid; urea; or any mixtures thereof. One preferred exfoliation promoters are 3,6,9-trioxaundecanedioic acid, glycolic acid, lactic acid, or any mixtures thereof (See also, INCI at p. 2205).
- When an embodiment of the invention includes an exfoliation promoter, the composition has about 0.1 weight % to 30 weight %, preferably about 1 weight % to about 15 weight % and more preferably about 1 weight % to about 10 weight %, of the exfoliation promoter based on the total weight of the composition.
- An antioxidant functions, among other things, to scavenge free radicals from skin to protect the skin from environmental aggressors. Examples of antioxidants that may be used in the present compositions include compounds having phenolic hydroxy functions, such as ascorbic acid and its derivatives/esters; beta-carotene; catechins; curcumin; ferulic acid derivatives (e.g. ethyl ferulate, sodium ferulate); gallic acid derivatives (e.g. propyl gallate); lycopene; reductic acid; rosmarinic acid; tannic acid; tetrahydrocurcumin; tocopherol and its derivatives; uric acid; or any mixtures thereof. Other suitable antioxidants are those that have one or more thiol functions (—SH), in either reduced or non-reduced form, such as glutathione, lipoic acid, thioglycolic acid, and other sulfhydryl compounds. The antioxidant may be inorganic, such as bisulfites, metabisulfites, sulfites, or other inorganic salts and acids containing sulfur. Compositions of the present invention may have an antioxidant preferably from about 0.001 weight % to about 10 weight %, and more preferably from about 0.01 weight % to about 5 weight %, of the total weight of the composition. (See also, INCI at p. 2184).
- In one embodiment of the invention, the composition may also have one or more of the following cosmetic and pharmaceutical active agents, excipients, ingredients, or adjuvants: anesthetics, antibiotics, e.g., erythromycins and tetracyclines, salicylic acids, anti-allergenics, antifungals, antiseptics, anti-irritants, anti-inflammatory agents, antimicrobials, analgesics, nitric oxide synthase inhibitors, insect repellents, self-tanning agents, skin penetration enhancers, skin cooling agents, chelating agents, colorants including dyes, lakes and pigments that may be untreated or chemically surface treated to improve wettability or some other property, demulcents, emollients, emulsifiers, fragrances, humectants, lubricants, skin protectants, moisturizers, pH adjusters, preservatives, stabilizers, surfactants, thickeners, plasticizers, viscosity modifiers, vitamins, or any mixtures thereof. The amounts of these various substances are those that are conventionally used in the cosmetic or pharmaceutical fields to achieve their intended purposes, for example, they may constitute from about 0.01% to 20% of the total weight of the composition.
- Non-limiting examples of active agents for formulating into the compositions of the invention include those reagents having an effect on the treatment of wrinkles and/or fine lines, in addition to the actives as described, such as keratolytic agents, i.e., an active agent having desquamating, exfoliant, or scrubbing properties, or an active agent which can soften the horny layer of the skin. Other examples of anti-wrinkle or anti-fine line active agents include hydroxy acids and retinoids. These agents can be formulated, for example, in amounts of from about 0.01% to 5% by weight relative to the total weight of the composition.
- Suitable hydroxy acids include, for example, glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, 2-hydroxyalkanoic acid, mandelic acid, salicylic acid and alkyl derivatives thereof, including 5-n-octanoylsalicylic acid, 5-n-dodecanoylsalicylic acid, 5-n-decanoylsalicylic acid, 5-n-octylsalicylic acid, 5-n-heptyloxysalicylic acid, 4-n-heptyloxysalicylic acid and 2-hydroxy-3-methylbenzoic acid or alkoxy derivatives thereof, such as 2-hydroxy-3-methyoxybenzoic acid.
- Emulsifiers are typically present in the compositions of the invention in an amount of about 0.01 weight % to 30 weight %, by weight and preferably from about 0.1 weight % to 30 weight % by weight relative to the total weight of the composition. However, not all compositions will necessarily include emulsifiers. (See e.g., INCI at p. 2276-2285).
- Non-limiting examples of suitable thickening agents include xanthan gum, hydroxypropyl cellulose, hydroxyethyl cellulose, carbomer, gum acacia, Sepigel 305 (available from Seppic Co., France), and clays such as magnesium aluminum silicate. (See, e.g., INCI at p. 2293-2299).
- The topical compositions of the present invention may include, and their utility can be enhanced by, one or more humectants, such as ureas, pyrrolidone carboxylic acids, amino acids, sodium hyaluronates, certain polyols and other compounds with hygroscopic properties. (See INCI at p. 2244).
- The general activity and mildness to skin of the present topical compositions can also be enhanced by neutralization to pH about 3.5 to about 7.0, most preferably from pH about 3.7 to about 5.6. This neutralization is preferably accomplished with one or more of ammonium hydroxide, potassium hydroxide, sodium hydroxide, arginine or other amino acids, and/or triethanolamine.
- Exemplary retinoids include, without limitation, retinoic acid (e.g., all-trans or 13-cis) and derivatives thereof, retinol (Vitamin A) and esters thereof, such as retinol palmitate, retinol acetate and retinol propionate, and salts thereof.
- The nanoparticles and pigment of the present invention may be contained in a cosmetically or dermatologically acceptable vehicle, medium, diluent or carrier. The inventive compositions may be further formulated according to procedures known in the art to provide cosmetic compositions such as emulsions, gels, creams, lotions, masks, toners, serums, oils, water-in-oil, oil-in-water, water-oil-water triple emulsions having the appearance of a cream or gel, microemulsions, ointments, pastes, sticks, cakes, pencils, aerosol, and essences, as well as other topical cosmetic vehicles. It is also contemplated that topical compositions of the present invention can be incorporated into delivery systems such as liposomes and topical patches, tapes, and sprays.
- In addition, the compositions may be in the form of vesicular dispersions containing ionic and/or nonionic lipids, as described above. Dosage units suitable for such compositions are formulated according to the conventional knowledge and techniques used in the art.
- The following example describes specific aspects of the invention to illustrate the invention and provide a description of the present methods for those skilled in the art. The example should not be construed as limiting the invention, as the example merely provides specific methodology useful in the understanding and practice of the invention and its various aspects.
- This example examines the effect of adding nanoparticles to a composition comprising a color pigment in the concentration enough to effectively create optical effects observed in the moth eye. A Gretag MacBeth Color Eye 7000A Spectrophotometer was used to quantify transmittance, reflection and absorbance (Absorbance=100−(Total Transmittance+SCI Reflection)).
- Physical blends of compositions comprising nanoparticles were prepared using a speed mixer with silicone acrylate copolymer (KP 550 from Shin Etsu)—which is 40% polymer in isododecane (IDD). Solutions were cast on clean (optically transparent/colorless) glass plates to give a wet film thickness of approximately 125 microns and dried overnight to form dry films with a resulting dry film thickness of 21-25 microns based on solid content. Samples were prepared in duplicate. Average luminescence (L*) was collected directly using the same sample area for total reflection (specular component included—SCI) and scattered reflection (specular component excluded—SCE). Data was collected in two distinct areas for each sample, resulting in four data points per sample. The Q-test was used to remove erroneous data points. All error bars shown are ±one standard deviation. The summary of prepared samples is shown below in Tables 1 and 2. For the samples reported in Tables 1 and 2, the color pigment is carbon black (D&C Black #2) and values are reported as weight % of the whole composition.
-
FIG. 2 shows the reflectance (total reflection (SCI) and scattering reflection (SCE)) of 1, 2, 3, and 4 (control) which were prepared as shown in Table 2. The figure shows that the addition of silica nanoparticles of any kind reduces total reflection (SCI—specular component included) without changing diffuse reflection (SCE—specular component excluded), within error limits.compositions -
TABLE 2 Physical blends of compositions comprising nanoparticles Cadre Carbon Hydrophobic Degussa Black, Hydrophobic Amorphous Aeroxide D&C Silica Shells- Fumed LE 3KP-550, Black SH (Kobo Silica Fumed Film IDD, Total Batch # # 2 Products) #79684 Silica former Solvent (parts) 1 6.94 2.78 0 0 6.94 83.34 100 2 6.94 0 2.78 0 6.94 83.34 100 3 6.94 0 0 2.78 6.94 83.34 100 4 7.14 0 0 0 7.14 85.72 100 5 6.94 0 0 5.00 6.94 81.12 100 6 6.94 0 0 7.00 6.94 79.12 100 7 6.94 0 5.00 0 6.94 81.12 100 8 6.94 0 7.00 0 6.94 79.12 100 9 9.00 0 0 2.78 6.94 81.28 100 10 11.0 0 0 2.78 6.94 79.28 100 11 9.00 0 0 5.00 6.94 79.06 100 12 0 0 7.14 0 7.14 85.72 100 13 0 0 0 7.14 7.14 85.72 100 -
FIG. 3 shows the absorbance of 1, 2, 3, and 4 (control) which were prepared as shown in Table 2. The figure shows that the addition of silica of any kind increases absorption as compared to a pigment alone (composition 4).compositions -
FIG. 4 shows the reflectance (total reflection (SCI) and scattering reflection (SCE)) of 5, 6, 9, 11, and 4 (control) which were prepared as shown in Table 2. The figure shows that the addition of fumed silica to carbon black causes a decrease in total reflection and scattered reflection.compositions -
FIG. 5 shows the absorbance of 5, 6, 9, 11, and 4 (control) which were prepared as shown in Table 2. The figure shows that the addition of fumed silica to carbon black causes a decrease in total reflection.compositions - Table 3 summarizes the reflectance and absorbance of all compositions which were prepared as shown in Table 2.
-
TABLE 3 Absorbance and total reflectance of compositions disclosed in Table 2 Average Average L* STDEV L* L* (ref- STDEV L* STD Dev Batch (ref-SCI) (ref-SCI) SCE) (ref-SCE) Absorbance (Abs) 1 20.50 0.69 20.26 0.62 93.95 0.89 2 21.88 0.92 16.91 1.14 96.41 0.24 3 21.80 0.82 16.94 1.02 96.49 0.21 4 31.94 0.08 18.68 4.47 92.79 1.04 5 20.30 0.88 14.87 0.19 96.63 0.20 6 17.92 0.49 14.19 0.44 96.01 1.13 7 16.98 0.28 14.37 0.47 96.77 0.50 8 16.11 0.22 14.97 0.03 95.05 1.00 9 22.65 1.11 17.72 1.53 96.06 0.34 10 20.53 0.81 16.49 0.77 96.80 0.16 11 19.89 1.37 15.37 0.69 95.51 1.55 12 56.63 4.51 54.11 5.64 3.37 5.88 13 66.24 2.64 65.84 2.67 7.17 4.49 -
FIGS. 2-5 show that while the efficiency of color chroma and reduction of glossiness is dependent on the nanoparticle loading (wt %) and is effective for the types of silica tested, the greatest increase in absorbance was obtained when the silica (nanoparticle) to carbon-black (pigment) ratio is approximately 1.0:1.4. - Table 4 lists properties of three batches of compositions of this invention with fumed silica (
Degussa Aeroxide LE 3, fumed silica) nanoparticles along with a control batch without any nanoparticles (the full compositions of which are disclosed in Table 2). Table 4 shows that the presence of nanoparticles in a composition enhances the absorbance. In addition, Table 4 shows that as the weight ratio of nanoparticles plus pigment to film former increases, the percent total reflectance decreases. -
TABLE 4 Absorbance and reflectance of compositions with and without fumed silica (Aeroxide LE 3) nanoparticles. Weight % Weight % Weight ratio of carbon Weight % KP-550 pigment plus black Aeroxide LE 3 (film nanoparticles to film % % Total Batch# (pigment) (nanoparticles) former) former Absorbance Reflectance 4 7.14 0 7.14 1.0:1.0 92.8 7.0 (Control) 3 6.94 2.78 6.94 1.4:1.0 96.5 3.5 5 6.94 5.00 6.94 1.7:1.0 96.6 3.1 6 6.94 7.00 6.94 2.0:1.0 96.0 2.5 -
FIG. 6 a shows the absorbance for three (3) systems: 4.00% carbon black control with no nanoparticles (batch 14), 4.00% carbon black with 4.00% silica shell nanoparticles (batch 15), and 4.00% carbon black with 4.00% fumed silica nanoparticles (batch 16) which were prepared as shown in Table 5.FIG. 6 b shows the luminescence (L*) data for the three systems inFIG. 6 a. The figures shows that the addition of either 4.00% fumed silica nanoparticles or 4.00% silica shell nanoparticles results in increased absorbance and reduced luminescence resulting in enhanced contrast (darker) in comparison to the carbon black control (no nanoparticles). -
TABLE 5 Physical blends of compositions comprising nanoparticles Carbon Degussa Black, Hydrophobic Aeroxide D&C Silica Shells- LE 3KP-550, Black SH (Kobo Fumed Film IDD, Total Batch # # 2 Products) Silica former Solvent (parts) 14 4.00 0 0 7.00 89.00 100 15 4.00 4.00 0 7.00 85.00 100 16 4.00 0 4.00 7.00 85.00 100 - Table 6 summarizes the reflectance and absorbance of all compositions which were prepared as shown in Table 5.
-
TABLE 6 Absorbance and total reflectance of compositions disclosed in Table 5 Average L* Average L* Average Trans- Total L* Batch (ref-SCI) (ref-SCE) Absorbance mission (SCI) 14 29.91 3.28 93.73 0.08 6.2 15 27.04 5.03 94.86 0.03 5.1 16 21.32 2.98 95.15 1.51 3.3 -
FIG. 7 a shows the total transmission for three (3) systems: 4.00% carbon black control with no nanoparticles (batch 14), 4.00% carbon black with 4.00% silica shell nanoparticles (batch 15), and 4.00% carbon black with 4.00% fumed silica nanoparticles (batch 16).FIG. 7 b shows the total reflectance and scattered reflectance data for the three systems inFIG. 7 a. The figures show that addition of 4.00% fumed silica nanoparticles results in increased transmission, reduced total reflectance and reduced scattered reflectance. - The content of all patents, patent applications, published articles, abstracts, books, reference manuals and abstracts, as cited herein are hereby incorporated by reference in their entireties to more fully describe the state of the art to which the invention pertains. All concentrations recited in the specification and claims are reported as weight percents, unless otherwise indicated.
- It should be understood that the foregoing description is only illustrative of the present invention. Various alternatives and modifications can be devised by those skilled in the art without departing from the invention. Accordingly, the present invention is intended to embrace all such alternatives, modifications and variations that fall within the scope of the appended claims.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/040,800 US20140030300A1 (en) | 2008-01-08 | 2013-09-30 | Nanoparticle Compositions Providing Enhanced Color for Cosmetic Formulations |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/970,882 US9056053B2 (en) | 2008-01-08 | 2008-01-08 | Nanoparticle compositions providing enhanced color for cosmetic formulations |
| US14/040,800 US20140030300A1 (en) | 2008-01-08 | 2013-09-30 | Nanoparticle Compositions Providing Enhanced Color for Cosmetic Formulations |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/970,882 Continuation US9056053B2 (en) | 2008-01-08 | 2008-01-08 | Nanoparticle compositions providing enhanced color for cosmetic formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20140030300A1 true US20140030300A1 (en) | 2014-01-30 |
Family
ID=40844757
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/970,882 Expired - Fee Related US9056053B2 (en) | 2008-01-08 | 2008-01-08 | Nanoparticle compositions providing enhanced color for cosmetic formulations |
| US14/040,800 Abandoned US20140030300A1 (en) | 2008-01-08 | 2013-09-30 | Nanoparticle Compositions Providing Enhanced Color for Cosmetic Formulations |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/970,882 Expired - Fee Related US9056053B2 (en) | 2008-01-08 | 2008-01-08 | Nanoparticle compositions providing enhanced color for cosmetic formulations |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9056053B2 (en) |
| EP (1) | EP2229131A4 (en) |
| JP (1) | JP2011509256A (en) |
| CN (1) | CN101909580B (en) |
| AR (1) | AR070097A1 (en) |
| BR (1) | BRPI0821496A2 (en) |
| CA (1) | CA2710846A1 (en) |
| MX (1) | MX2010007471A (en) |
| TW (1) | TWI465256B (en) |
| WO (1) | WO2009088584A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9061056B2 (en) | 2010-08-27 | 2015-06-23 | Sienna Labs, Inc. | Compositions and methods for targeted thermomodulation |
| US9212294B2 (en) | 2012-10-11 | 2015-12-15 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
| US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9345649B2 (en) | 2006-12-21 | 2016-05-24 | Avon Products, Inc. | Cosmetic composition containing novel fractal particle-based gels |
| TWI411448B (en) | 2007-12-27 | 2013-10-11 | Avon Prod Inc | Optical blurring pigment composition suitable for use in cosmetics |
| US9364689B2 (en) * | 2009-12-22 | 2016-06-14 | Avon Products, Inc. | Cosmetic compositions comprising fibrous pigments |
| EP2519214A4 (en) | 2009-12-29 | 2016-01-20 | Grace W R & Co | COMPOSITIONS FOR FORMING FILMS HAVING DESIRED MASKING DEGREE AND METHODS OF MANUFACTURING AND USE THEREOF |
| IN2012DN05894A (en) | 2009-12-29 | 2015-09-18 | Grace W R & Co | |
| US9993397B2 (en) | 2010-11-23 | 2018-06-12 | Conopco Inc. | Composite particles and compositions with composite particles |
| CN104684531A (en) * | 2012-08-10 | 2015-06-03 | 莱雅公司 | A color cosmetic composition with increased color intensity |
| JP6445981B2 (en) * | 2012-12-27 | 2018-12-26 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Sunscreen composition comprising fatty acid and nonionic linear polymer |
| KR102214817B1 (en) | 2013-05-16 | 2021-02-15 | 디에스엠 아이피 어셋츠 비.브이. | Cosmetic composition comprising a collagen protecting or enhancing agent and particles comprising silica and titanium dioxide topical compositions |
| CN103819939A (en) * | 2014-02-12 | 2014-05-28 | 铜陵瑞莱科技有限公司 | Iron oxide red pigment containing wool fat |
| AU2015312014B2 (en) * | 2014-09-02 | 2020-11-05 | Edgewell Personal Care Brands, Llc | Mineral sunscreen compositions |
| TWI561251B (en) * | 2015-07-31 | 2016-12-11 | Univ Nat Tsing Hua | Sun protection composition and application the same |
| WO2017032628A1 (en) * | 2015-08-21 | 2017-03-02 | Unilever N.V. | A cosmetic mask |
| MX2019003001A (en) * | 2016-09-15 | 2019-10-02 | Toyo Aerosol Ind Co | Chemiluminescent aerosol product. |
| CN109745234B (en) * | 2017-11-08 | 2022-10-28 | 嘉创投资有限公司 | A kind of cosmetic with color metal film effect |
| JP7441168B2 (en) * | 2017-11-08 | 2024-02-29 | エレガントベストインベストメントリミテッド | Make-up film with colored metallic effect |
| JP7042302B2 (en) * | 2019-06-06 | 2022-03-25 | 花王株式会社 | Particle-containing composition |
| EP4073176B1 (en) * | 2019-12-11 | 2025-08-20 | Natura & Co UK Holdings Limited | Compositions with increased color shade stability based on pigmentary tio2, organic pigments and metal oxide particles |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356617A (en) * | 1990-05-14 | 1994-10-18 | Kobo Products, Inc. | Pigment-material-microsphere complexes and their production |
| US6001373A (en) | 1993-10-02 | 1999-12-14 | The Procter & Gamble Company | Cosmetic make-up compositions |
| JP3492790B2 (en) | 1994-10-03 | 2004-02-03 | カネボウ株式会社 | Makeup cosmetics |
| ES2110857T3 (en) | 1995-06-21 | 1998-02-16 | Oreal | COSMETIC COMPOSITION THAT INCLUDES A DISPERSION OF PARTICLES OF POLYMER. |
| FR2735690B1 (en) * | 1995-06-21 | 1997-09-12 | Oreal | COMPOSITION IN THE FORM OF A CAST PRODUCT COMPRISING A POLYMER DISPERSION |
| JP3605938B2 (en) | 1996-03-29 | 2004-12-22 | 株式会社コーセー | Eyelash cosmetics |
| US5885921A (en) * | 1996-10-25 | 1999-03-23 | Ligochem, Inc. | Hydrophobic silica adsorbents for lipids |
| FR2788687B1 (en) * | 1998-12-14 | 2002-05-31 | Oreal | MASCARA PRODUCT COMPRISING A POLYURETHANE |
| JP2001187715A (en) | 1999-12-28 | 2001-07-10 | Kose Corp | Cosmetic eye liner |
| FR2818898B1 (en) * | 2001-01-04 | 2003-03-28 | Oreal | USE OF CARBON BLACK AS A BENDING AGENT AND METHOD FOR IMPROVING THE BENDING OF KERATINIC FIBERS |
| FR2818900B1 (en) * | 2001-01-04 | 2003-03-28 | Oreal | USE OF CARBON BLACK AS AN AGENT FOR IMPROVING THE WATER RESISTANCE OF A MAKE-UP COMPOSITION OF KERATINIC MATERIALS |
| FR2823104B1 (en) * | 2001-04-10 | 2005-06-10 | Oreal | MASCARA COMPRISING AN ACRYLIC POLYMER |
| JP2003113043A (en) | 2001-09-28 | 2003-04-18 | Kose Corp | Cosmetic for eyelashes |
| FR2836243B1 (en) | 2002-02-18 | 2005-01-28 | Synelec Telecom Multimedia | RETROPROJECTION SCREEN AND METHOD FOR MANUFACTURING THE SAME |
| JP2004168662A (en) | 2002-11-15 | 2004-06-17 | Kose Corp | Eye makeup cosmetic |
| JP2004189687A (en) | 2002-12-13 | 2004-07-08 | Kanebo Ltd | Color-transfer preventing makeup cosmetic |
| US7993632B2 (en) | 2002-12-20 | 2011-08-09 | L'oreal S.A. | Composition for coating keratin fibres having a threading nature |
| FR2848824B1 (en) * | 2002-12-20 | 2005-05-20 | Oreal | COMPOSITION FOR COATING KERATINOUS FIBERS HAVING A FILTERING CHARACTER |
| JP4195820B2 (en) | 2003-02-07 | 2008-12-17 | 株式会社コーセー | Water-in-oil mascara |
| US20050058678A1 (en) | 2003-08-01 | 2005-03-17 | Audrey Ricard | Two-coat cosmetic product, uses thereof and makeup kit comprising the same |
| FR2858214B1 (en) * | 2003-08-01 | 2006-01-27 | Oreal | COSMETIC BILOUCHE PRODUCT, USES THEREOF, AND MAKE-UP KIT CONTAINING THE SAME |
| FR2858550B1 (en) * | 2003-08-06 | 2007-05-18 | Oreal | MAKE-UP COMPOSITION OF KERATINIC MATERIALS, IN PARTICULAR KERATIN FIBERS, LIKE THE CILES. |
| FR2861290B1 (en) | 2003-10-24 | 2006-02-10 | Oreal | THERMOGONFLANT COSMETIC COMPOSITION. |
| FR2884413A1 (en) * | 2005-04-19 | 2006-10-20 | Oreal | COSMETIC COMPOSITION COMPRISING SILICA PARTICLES, REFLECTIVE PARTICLES AND AT LEAST ONE PARTICULAR POLYMER, PROCESS FOR PREPARATION AND USES |
| US20060257336A1 (en) | 2004-04-19 | 2006-11-16 | Veronique Ferrari | Cosmetic composition comprising silica particles, reflecting particles, and at least one polymer, preparative processes, and uses thereof |
| ES2328709T3 (en) * | 2004-07-16 | 2009-11-17 | L'oreal | A SOLID COSMETIC EMULSION OF WATER IN OIL. |
| FR2873019B1 (en) * | 2004-07-16 | 2008-02-15 | Oreal | SOLID WATER-IN-OIL COSMETIC EMULSION |
| US20060013792A1 (en) | 2004-07-16 | 2006-01-19 | Jacqueline Fontaine | Solid water-in-oil cosmetic emulsion |
| US20060013793A1 (en) | 2004-07-16 | 2006-01-19 | Agnes Themens | Solid water-in-oil cosmetic emulsion |
| JP4763258B2 (en) | 2004-08-31 | 2011-08-31 | 株式会社コーセー | Oily solid cosmetic |
| JP2006273806A (en) * | 2005-03-30 | 2006-10-12 | Kose Corp | Cosmetic for eyelash |
| US20070071700A1 (en) | 2005-09-23 | 2007-03-29 | Anjali Abhimanyu Patil | Cosmetic compositions containing silicone/organic copolymers |
| JP4920948B2 (en) | 2005-10-28 | 2012-04-18 | 株式会社コーセー | Non-emulsifying aqueous two-layer makeup cosmetic |
| US9993403B2 (en) | 2007-12-20 | 2018-06-12 | Avon Products, Inc. | Cosmetic compositions for imparting superhydrophobic films |
| TWI411448B (en) * | 2007-12-27 | 2013-10-11 | Avon Prod Inc | Optical blurring pigment composition suitable for use in cosmetics |
-
2008
- 2008-01-08 US US11/970,882 patent/US9056053B2/en not_active Expired - Fee Related
- 2008-11-28 TW TW097146497A patent/TWI465256B/en not_active IP Right Cessation
- 2008-12-02 CA CA2710846A patent/CA2710846A1/en not_active Abandoned
- 2008-12-02 JP JP2010541462A patent/JP2011509256A/en active Pending
- 2008-12-02 WO PCT/US2008/085216 patent/WO2009088584A1/en not_active Ceased
- 2008-12-02 MX MX2010007471A patent/MX2010007471A/en active IP Right Grant
- 2008-12-02 EP EP08869635.6A patent/EP2229131A4/en not_active Withdrawn
- 2008-12-02 BR BRPI0821496-4A2A patent/BRPI0821496A2/en not_active Application Discontinuation
- 2008-12-02 CN CN200880124181.1A patent/CN101909580B/en not_active Expired - Fee Related
-
2009
- 2009-01-05 AR ARP090100012 patent/AR070097A1/en unknown
-
2013
- 2013-09-30 US US14/040,800 patent/US20140030300A1/en not_active Abandoned
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9439964B2 (en) | 2010-08-27 | 2016-09-13 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of the skin surface with coated metal nanoparticles |
| US9439965B2 (en) | 2010-08-27 | 2016-09-13 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of the skin surface with metal nanoparticles in surfactant containing solutions |
| US11826087B2 (en) | 2010-08-27 | 2023-11-28 | Coronado Aesthetics, Llc | Compositions and methods for thermal skin treatment with metal nanoparticles |
| US9421259B2 (en) | 2010-08-27 | 2016-08-23 | Sienna Biopharmaceuticals, Inc. | Hair removal with coated metal nanoparticles |
| US9421260B2 (en) | 2010-08-27 | 2016-08-23 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of acne with nanoparticles with coatings that facilitate selective removal from the skin surface |
| US9421261B2 (en) | 2010-08-27 | 2016-08-23 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of the skin surface with nanoparticles with coatings that facilitate selective removal from the skin surface |
| US9427467B2 (en) | 2010-08-27 | 2016-08-30 | Sienna Biopharmaceuticals, Inc. | Hair removal with metal nanoparticles in surfactant containing solutions |
| US9433676B2 (en) | 2010-08-27 | 2016-09-06 | Sienna Biopharmaceuticals, Inc. | Hair removal with nanoparticles with coatings that facilitate selective removal from the skin surface |
| US9433678B2 (en) | 2010-08-27 | 2016-09-06 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of acne with metal nanoparticles in surfactant containing solutions |
| US9433677B2 (en) | 2010-08-27 | 2016-09-06 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of a pilosebaceous unit with metal nanoparticles in surfactant containing solutions |
| US11419937B2 (en) | 2010-08-27 | 2022-08-23 | Coronado Aesthetics, Llc | Delivery of nanoparticles |
| US9446126B2 (en) | 2010-08-27 | 2016-09-20 | Sienna Biopharmaceuticals, Inc. | Thermal treatment of acne with coated metal nanoparticles |
| US9061056B2 (en) | 2010-08-27 | 2015-06-23 | Sienna Labs, Inc. | Compositions and methods for targeted thermomodulation |
| US10537640B2 (en) | 2010-08-27 | 2020-01-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
| US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
| US9526745B2 (en) | 2012-10-11 | 2016-12-27 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
| US10688126B2 (en) | 2012-10-11 | 2020-06-23 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
| US9212294B2 (en) | 2012-10-11 | 2015-12-15 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
| US11583553B2 (en) | 2012-10-11 | 2023-02-21 | Nanocomposix, Llc | Silver nanoplate compositions and methods |
| US9249334B2 (en) | 2012-10-11 | 2016-02-02 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
| US12029831B2 (en) | 2012-10-11 | 2024-07-09 | Coronado Aesthetics, Llc | Silver nanoplate compositions and methods |
Also Published As
| Publication number | Publication date |
|---|---|
| US9056053B2 (en) | 2015-06-16 |
| EP2229131A4 (en) | 2013-10-16 |
| CN101909580B (en) | 2012-11-07 |
| BRPI0821496A2 (en) | 2014-09-30 |
| JP2011509256A (en) | 2011-03-24 |
| HK1146222A1 (en) | 2011-05-20 |
| MX2010007471A (en) | 2010-10-05 |
| US20090175915A1 (en) | 2009-07-09 |
| AR070097A1 (en) | 2010-03-17 |
| TW200932281A (en) | 2009-08-01 |
| TWI465256B (en) | 2014-12-21 |
| CA2710846A1 (en) | 2009-07-16 |
| WO2009088584A1 (en) | 2009-07-16 |
| EP2229131A1 (en) | 2010-09-22 |
| CN101909580A (en) | 2010-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9056053B2 (en) | Nanoparticle compositions providing enhanced color for cosmetic formulations | |
| US20080220026A1 (en) | Mesoporous material compositions and methods of their use for improving the appearance of biological surfaces | |
| TWI505849B (en) | Multistep cosmetic compositions | |
| WO2008079758A1 (en) | Nanocomposite pigments in a topical cosmetic application | |
| WO2008079760A2 (en) | Nanocomposite pigments in a topical cosmetic application | |
| US9561163B2 (en) | Cosmetic composition containing novel fractal particle-based gels | |
| JP6766047B2 (en) | Γ-diketone for the treatment and prevention of aging skin and wrinkles | |
| US20080219940A1 (en) | Colored cosmetic composition having soft focus effect | |
| US20080070993A1 (en) | Additives for cosmetic products and the like | |
| CN111888284A (en) | Cosmetic composition | |
| JPH0840825A (en) | Surfactant-free oil-in-water emulsion stabilized with hollow thermoplastic particles | |
| CA2378644A1 (en) | Use of fibres as an anti-irritant agent in a cosmetic or dermatological composition | |
| US20060134035A1 (en) | Long wear topical composition having improved glossy appearance | |
| US20150190332A1 (en) | Multi-layer cosmetic films | |
| RU2685712C2 (en) | Local application compositions containing resorcine and powders | |
| WO2008079543A9 (en) | Mesoporous material compositions and methods of their use for improving the appearance of biological surfaces | |
| HK1146222B (en) | Nanoparticle compositions providing enhanced color for cosmetic formulations | |
| JP2023094350A (en) | Hair cosmetic | |
| HK1145645A (en) | Multistep cosmetic compositions | |
| BR102017006568B1 (en) | TOPIC USE COSMETIC COMPOSITION AND USE OF A COSMETIC COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: AVON PRODUCTS, INC., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAITRA, PRITHWIRAJ;CARLO, STEVEN;RANADE, RAHUL A.;REEL/FRAME:034042/0432 Effective date: 20080103 |
|
| AS | Assignment |
Owner name: CITIBANK, N.A., NEW YORK Free format text: SECURITY INTEREST;ASSIGNOR:AVON PRODUCTS, INC.;REEL/FRAME:035899/0776 Effective date: 20150605 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |
|
| AS | Assignment |
Owner name: AVON PRODUCTS, INC., NEW YORK Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:039690/0331 Effective date: 20160815 |